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resumo 
 
 
O estabelecimento de culturas celulares primárias constitui um aspecto 
relevante para o estudo da biologia celular e molecular. Várias linhas celulares 
humanas estão disponíveis contudo, muitas adquiriram alterações genéticas 
significativas, incluindo a delecção de importantes genes reguladores. Neste 
sentido, é importante a criação de novos métodos que permitam aceder ao 
natural comportamento celular. Para analisar as actividades celulares 
relacionadas com a expressão de proteínas extracelulares da matriz, 
determinantes no processo de ramificação das neurites, procedeu-se ao 
desenvolvimento de um novo protocolo para isolamento e estabelecimento de 
culturas neuronais embrionárias de rato utilizando cardosinas. 
As cardosinas são proteases aspárticas de plantas, extraídas dos pistilos de 
Cynara cardunculus L., tendo sido usadas neste trabalho como uma nova 
ferramenta para desagregação de tecidos. As cardosinas foram comparadas 
com a tripsina, em termos de efeito durante o processo de isolamento de 
neurónios corticais. Conjuntamente, os resultados morfológicos e funcionais 
sugerem uma potencial aplicação das cardosinas em técnicas de isolamento 
de diferentes tipos celulares. Os resultados apresentam vantagens claras, em 
termos da viabilidade celular, do rendimento, sugerindo a implementação das 
cardosinas para isolamento celular, em alternativa à tripsina. 
Os neurónios corticais resultantes atingiram rácios de expressão MMPs/TIMPs 
após 24 horas em cultura proporcionais ao desenvolvimento e proliferação das 
neurites. A célere recuperação celular do processo de isolamento está 
relacionada com uma especificidade mais restrita das cardosinas o que 
suporta a sua aplicação, não só para o estabelecimento de culturas primárias, 
mas também para os procedimentos de subcultivo. Esta recuperação mais 
rápida sugere que, durante a desagregação do tecido nervoso, as cardosinas 
seguem um mecanismo menos agressivo para os neurónios que a tripsina. 
Este aspecto pode ter particular interesse em procedimentos de 
autotransplante, uma vez que a manipulação das culturas celulares deve 
preservar a integridade celular, para uma consequente reabilitação mais rápida 
do paciente.  
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abstract 
 
The establishment of primary cell cultures is invaluable for studying cell and 
molecular biological questions. A variety of human cell lines exist, however, 
most have acquired significant genetic alterations from their cells of origin, 
including deletion of important regulatory genes. Therefore is important to 
create new methods to ascertain natural cell behaviour.  In order to analyze 
cellular activities related to extracellular matrix protein expression, determinant 
for neurite pathfinding, a new protocol was established for isolating and 
culturing neuronal cells from embryonic rats by using cardosins. 
Cardosins are plant aspartic proteinases extracted from the pistils of Cynara 
cardunculus L. and were used in the present work as novel tool for tissue 
disaggregation. Cardosins were compared to trypsin effect in the isolation of 
cortical neurons. Both morphological and functional data suggest a potential 
application of cardosins in isolation techniques for different cellular types. The 
results demonstrate clear advantages, in terms of improved cell viability, 
increased yields, suggesting cardosins implementation as alternative to use 
trypsin for cell isolation. 
The resultant cortical neurons revealed to achieve MMPs/TIMPs expression 
ratio after the first 24 hours in culture matching with a superior neurite 
outgrowth and dendritic extension. This early cell recovery to isolation 
procedure is related to the narrow specificity of cardosins that support their 
application for establishment of primary cell culture and for subcultivation 
procedures. The increase on neuronal recover after cell plating suggesting that, 
during brain disaggregation, cardosins follow a mechanism that is less 
aggressive to neurons than trypsin. This could be particularly interesting for 
autotransplantation procedures, as cell culture manipulation would preserve 
cell integrity, leading to a faster patient rehabilitation. 
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The brain is the only organ that studies itself and 
Neuroscience is a multidisciplinary study of the brain and 
its performance. It is a new discipline that has grown out 
of modern needs to solve practical medical problems as 
well as address the continuing human desire to discover 
more about ourselves. 
The ancestral Alkmaion of Croton (500 - 450 BC, Greece) 
was the first to place sensation in the brain and claimed 
that there was a conduct to transmit the sensory 
impressions that external objects made on the eyes - and 
he concluded that the brain was the seat of the intellect, 
and thus was one of the first cephalocentric protagonists. 
Presently, neuroscientists are interested in questions such 
as: What is mind? Why do we need to sleep? Why do 
people feel emotions? What causes Alzheimer's Disease? 
What happens in the brain when we learn? And how 
does brain develop before birth? Neuroscience is 
nowadays a combined field that integrates Psychology, 
Biology, Chemistry, and several other traditional 
disciplines in the study of brain structure, physiology and 
behaviour including human emotional and cognitive 
functions. 
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1. INTRODUÇÃO 
1.Introdução 
1. Introduction 
 
 
Research using human and animal cell preparations continues to be an 
extremely active area of investigation.  In fact, it has become very beneficial 
for diverse applications in biotechnology and biomedical research. Originally 
used as substrates for the production of viral vaccines, cell cultures became an 
indispensable tool to produce a variety of products, including 
biopharmaceuticals, monoclonal antibodies and products for gene therapy.  
The use of cell cultures constitutes also adequate test systems for studying 
biochemical pathways, pathological mechanisms or intra- and intercellular 
responses. Human cell culture, stem cell culture in particular, is developing new 
research tools, new knowledge about pathways of cell differentiation and 
opening new perspectives of cell transplantation therapy for human diseases. 
For instance, transplantation of embryonic dopaminergic neurons has been 
performed in animals and in patients with Parkinson’s disease for several 
years1,2,3. However, the availability of human embryonic donor tissue for clinical 
transplantations is limited and only 5-10% of the grafted neurons survive4. 
To overcome these limitations there is a need to develop strategies to improve 
cell survival. Not only for transplantation purposes but for general applications 
of cell cultures where it is crucial to preserve cell integrity and its native features. 
The establishment of primary cell cultures is invaluable for studying cell and 
molecular biological issues. A variety of human cell lines exist, however, most 
have acquired significant genetic alterations from their cells of origin, including 
deletion of important regulatory genes. Therefore is important to create new 
methods to ascertain natural cell behaviour.   
 
To achieve maximal neuroprotection is important to be aware to the steps of 
cell preparation procedures when cell death is pronounced. 
                                                          
1 Hagell P, Brundin P (2001). Cell survival and clinical outcome following intrastriatal transplantation in 
Parkinson disease. J Neuropathol Exp Neurol. 60(8): 741-52. Review. 
2 Lindvall O, Hagell P. Clinical observations after neural transplantation in Parkinson’s disease, in: S.B. Dunnett, 
A. Bjo¨rklund (Eds.), Progress in Brain Research, Vol. 127, Elsevier Science, 2000, pp. 299-320. 
3 Karlsson J, Emgard M, Brundin P. (2002). Comparison between survival of lazaroid-treated embryonic nigral 
neurons in cell suspensions, cultures and transplants. Brain Res. 955(1-2): 268-80. 
4 Kordower JH, Freeman TB, Chen EY, Mufson EJ, Sanberg PR, Hauser RA, Snow B, Olanow CW (1998). Fetal 
nigral grafts survive and mediate clinical benefit in a patient with Parkinson’s disease, Mov. Disord. 13 383–393. 
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The most important stage that involves cell death is during brain dissection and 
enzymatic dissagregation for cell dissociation. During this phase, characterised 
by enzymatic cleavage of extracellular matrix (ECM) components or 
membrane-associated proteins, neurons are axotomized and cell–cell contact 
is disrupted which may lead to apoptosis compromising cell isolation 
efficiency3,5. 
The ECM molecules that are particularly implicated in the major steps of 
nervous system development are the basal membrane components; however, 
it is not easy to understand the exact roles of each molecule because of their 
complexity and redundancy. Interactions between cells and their surrounding 
ECM are required to generate the specific features of tissue architecture. 
During neuronal development, the growth cone, the leading structure of 
growing axons, senses guidance cues from the surrounding environment and 
implements directed outgrowth. Axonal regeneration requires extensive growth 
cone motility and infiltration within damaged and degenerating nervous tissue. 
Substantial evidence now indicates that neurons secrete matrix-degrading 
enzymes and actively remodel surrounding ECM substrata of the mammalian 
nervous system6,7,8. Axon outgrowth can thus perform as a concept for tissue 
invasion in tumorigenesis. Neuronal cells growth cone "sniffs out" the 
extracellular environment for signals that instruct the axon which way to grow. 
These signals, called guidance cues, can be fixed in place or diffusible; they 
can attract or repel axons. It has long been conjured that proteolytic activity 
on neuronal growth cones controls their migratory activity9. Matrix 
metalloproteinases (MMP) form one of the most important families of 
proteinases that participate in the processing of bioactive molecules. It is 
believed that the main function of proteases is to create penetrable paths for 
axon extension and to modulate the activities of receptors and ligands through 
proteolytic processing. Both roles have been clearly demonstrated in recent 
studies. Plasminogen activators and MMPs are expressed by neurons and 
                                                          
5 Li AE, Ito H, Rovira I, Kim K, Takeda K, Yu ZY, Ferrans VJ, Finkel T (1999). A role for reactive oxygen species in 
endothelial cell anoikis. Circ. Res. 85: 304–310. 
6 Monard D (1988) Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth. Trends 
Neurosci 11:541-544. 
7 Pittman RN, Buettner HM (1989) Degradation of extracellular matrix by neuronal proteases. Dev Neurosci 
11:361-375. 
8 Fambrough D, Pan D, Rubin GM, Goodman CS (1996) The cell surface metalloprotease/disintegrin 
Kuzbanian is required for axonal extension in Drosophila. Proc Natl Acad Sci USA 93:13233-13238. 
9 Krystosek, A. and Seeds, N.W. (1981) Plasminogen activator release at the neuronal growth cone. Science 
213, 1532–1534. 
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released by growth cones, implicating the growing tip of axons in the 
proteolysis of ECM substrata10. 
Hence, MMPs relevance in neuronal growth and regeneration constitutes 
another important remark of the present study. The matrix metalloproteinases 
have been viewed as bulldozers11, destroying the extracellular matrix to permit 
normal remodelling and contribute to pathological tissue destruction and 
tumour cell invasion. More recently, the identification of specific matrix and 
non-matrix substrates for MMPs and the elucidation of the biological 
consequence of cleavage indicate that we need to expand upon the 
simplistic view that MMPs punch holes in basement membrane and 
extracellular matrix structures to a much more sophisticated vision of specific 
proteolytic events.  
MMPs can regulate the bioavailability and/or activity of growth factors by 
cleavage of both matrix and non-matrix substrates or by mediating receptor 
turnover, and their activity is independent of the tissue source.  
 
There are some general examples of MMPs that directly cleave and activate 
growth factors. MMP-2 and MMP-9 directly process TGF-β into an active 
ligand12. Proteolytic processing of interleukin 1-β (IL1-β) from its precursor form to 
an active form has been reported to be carried out by MMP-2, MMP-3 and 
MMP-913. 
Cell migration is a complex process that requires the coordinated regulation of 
cell–cell attachments, cell–matrix attachment and matrix remodelling. It seems 
intuitive that matrix proteolysis could directly modulate cell–matrix adhesion 
either by removal of sites of adhesion or by exposing a binding site. This can 
translate into an effect on cell migration, as MMP-2-dependent cleavage of 
laminin-5 induces keratinocyte migration14 and MT1-MMP cleavage of laminin-5 
allows migration of a variety of cell types15. 
                                                          
10
 Teesalu T, Kulla A, Asser T, Koskiniemi M, Vaheri A (2002). Tissue plasminogen activator as a key effector in 
neurobiology and neuropathology. Biochem Soc Trans 30(2):183-9. 
11 McCawley LJ, Matrisian LM (2001). Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin 
Cell Biol.13(5):534-40. Review. 
12 Yu Q, Stamenkovic I (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β 
and promotes tumor invasion and angiogenesis. Genes Dev 14: 163-176. 
13 Schonbeck U, Mach F, Libby P (1998). Generation of biologically active IL-1β by matri mxetalloproteinases: 
a novel caspase-1-independent pathway of IL-1β processing. J Immunol, 161:3340-3346. 
14Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V (1997). Induction of cell migration 
by matrix metalloprotease-2 cleavage of laminin-5. Science, 277: 225-228. 
15 Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V (2000). Role of cell surface metalloprotease MT1-
MMP in epithelial cell migration over laminin-5. J Cell Biol, 148:615-624. 
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MMP activity may also modulate attachment and migration by cleaving 
cell-cell or cell-matrix receptors directly. For example, β4 integrin is cleaved by 
MMP-716, and MMP mediated proteolytic removal of E-cadherin has been 
demonstrated17.  
Cell migration is often initiated in response to a chemotactic stimulus. MMPs 
generate a chemotactic signal in several systems. MMP-9 is required for the 
release of vascular endothelial growth factor (VEGF) during long bone 
development, VEGF then acts as a chemoattractant for osteoblast 
recruitment18. MMPs also play a role in balance the chemotactic response. For 
example, monocyte chemoattractant protein (MCP)-3 is cleaved and 
inactivated by MMP-2, attenuating chemotaxis and the inflammatory 
response19. 
 
Perhaps the most significant consequence of the overexpression of 
metalloproteinases in the central nervous system (CNS) is the regulation of cell 
survival and death. Various mechanisms contribute to metalloproteinase-
mediated cell death. The adherence of cells to the ECM provides survival 
signals through mechanisms that include the activation of integrin receptors 
that have engaged particular ECM proteins. When such anchored cells are 
detached from the substratum, the loss of integrin signalling can result in 
apoptosis, a phenomenon that has been referred to as anoikis.  
 
Therefore, in the CNS, the degradation of ECM proteins and loss of integrin 
signalling by abnormally expressed MMPs can affect cell survival. 
As pointed out before, in the nervous system there is substantial evidence that 
MMPs regulate axonal growth. The metalloproteinase activity is localized to the 
growth cones of neurons, and inhibition of metalloproteinase activity reduces 
growth cone motility20.  
                                                          
16 Von Bredow DC, Nagle RB, Bowden GT, Cress AE (1997): Cleavage of β4 integrin by matrilysin. Exp Cell Res 
236: 341-345. 
17 Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M 
(2001). Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci, 
114:111-118. 
18 Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, 
Delaisse JM (2000). Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for 
osteoclast recruitment into developing long bones. J Cell Biol, 151:879-890. 
19 McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM (2000). Inflammation 
dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science, 289: 1202-1206. 
20 Sheffield JB, Krasnopolsky V,  Dehlinger E (1994). Inhibition of retinal growth cone activity by specific 
metalloproteinase inhibitors in vitro. Dev. Dyn. 200, 79–88. 
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Additionally, growth factors and ECM molecules that promote neurite 
outgrowth, such as nerve growth factor (NGF) and laminin, have been 
correlated to an increase the expression of MMP-2 in neurons21. Several studies 
have demonstrated that MMPs have roles in axonal elongation21 and are also 
implicated in their guidance22 during normal development. Following injury 
there is no evidence that metalloproteinases facilitate regeneration of axons in 
vivo, but various lines of facts point towards this potential. One example is given 
by expression of metalloproteinases has been shown to correspond with periods 
of recovery. In regenerating sciatic nerve fibres, MMP-9 expression is 
co-localized with phosphorylated neurofilament M, a marker for regenerative 
elongation; the phosphorylated neurofilament M is also induced by MMP-9 
treatment and inhibited by an anti-MMP-9 antibody treatment23,24. 
Overall, these studies emphasize that when MMPs are expressed in a spatially 
and temporally restricted manner during development or after an insult, they 
can have important roles.  
 
Indeed, MMPs can perform either beneficial or detrimental activities in the CNS. 
Although these findings show that the net effect of the acute upregulation of 
many metalloproteinases in nervous system pathology is detrimental, certain 
MMPs that are discreetly expressed at specific sites, particularly during the 
repair or recovery phase, can have beneficial activity. For example, MMP-9 is 
detrimental in multiple sclerosis and in acute insults to the nervous system, such 
as stroke and spinal cord injury. However, MMP-9 has a beneficial effect on 
repair processes such as axonal regeneration and remyelination. 
At least three factors might determine whether metalloproteinases are 
beneficial or detrimental after nervous system injuries: the stage of CNS injury, 
the type of injury inflicted, and the pathophysiology of the disorder involved. 
Metalloproteinases are implicated in diseases of the nervous system, and, 
therapeutically, it is important to target their activity. Although the long-term 
                                                          
21 Weeks BS, Nomizu M, Ramchandran RS, Yamada Y, Kleinman HK (1998). Laminin-1 and the RKRLQVQLSIRT 
laminin-1 α1 globular domain peptide stimulate matrix metalloproteinase secretion by PC12 cells. Exp. Cell 
Res. 243: 375–382. 
22 Webber CA, Hocking JC, Yong VW, Stange CL, McFarlane S (2002). Metalloproteases and guidance of 
retinal axons in the developing visual system. J. Neurosci. 22: 8091–8100. 
23 Shubayev VI, Myers RR (2004).  Matrix metalloproteinase-9 promotes nerve growth factor-induced neurite 
elongation but not new sprout formation in vitro. J. Neurosci. Res. 77: 229–239. 
24 Demestre M, Wells GM, Miller KM, Smith KJ, Hughes RA, Gearing AJ, Gregson NA. (2004). Characterisation of 
matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve 
regeneration. Neuroscience 124, 767–779. 
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impact of metalloproteinase inhibitors in neurological conditions is not clear 
because of the complexity of metalloproteinase function, the evidence 
suggests that the short-term use of inhibitors after acute insults such as stroke 
and spinal cord injury will have beneficial outcomes.  
 
In addition to MMPs, TIMPs (tissue inhibitors of metalloproteinases) expression 
has been implicated in several inflammatory disease of CNS. For example, the 
idea that TIMP-1 up-regulation modulates the general neuronal responses 
following excitotoxic injury has received increased attention in the recent 
literature. Tan and co-workers (2003)25 showed that application of TIMP-1 
protected neurons against excitotoxic injury induced with glutamate.  
Nevertheless, in vitro studies with primary human fetal astrocytes and further 
biological conformation using cerebrospinal fluid and brain tissue reflected 
differential TIMP-1 regulation. TIMP-1 mRNA and protein increased significantly 
with acute activation of astrocytes with IL-1β; however, cerebrospinal fluid and 
brain tissue from human immunodeficiency virus (HIV)-1-associated dementia 
patients showed significant down-regulation26. The reduction in protein 
expression ultimately brings about withdrawal of TIMP-1 neuroprotection and 
enhanced neuronal malfunction. These studies demonstrate that astrocytes 
may behave differently with acute versus chronic activation. 
Gardner & Ghorpade (2003)27 proposed a model for astrocyte TIMP-1 
regulation in acute and chronic inflammation. Acute activation of neural cells 
(astrocytes, microglia, and neurons) by proinflammatory cytokines such as IL-1β 
may lead to enhanced levels of TIMP-1 in the tissue microenvironment and elicit 
a typical repair response early in injury (Fig. 1.1 A). In contrast, under sustained 
inflammatory conditions, such as those observed in chronic neurodegenerative 
diseases (human immunodeficiency virus (HIV)-1-associated dementia and 
Alzheimer’s disease), TIMP-1 levels in the CNS decline significantly below 
homeostatic levels (Fig. 1.1 B). 
                                                          
25 Tan HK, Heywood D, Ralph GS, Bienemann A, Baker AH, Uney JB (2003). Tissue inhibitor of metalloproteinase 
1 inhibits excitotoxic cell death in neurons. Mol Cell Neurosci 22: 98 –106. 
26 Suryadevara R, Holter S, Borgmann K, Persidsky R, Labenze-Zink C, Persidsky Y, Gendelman HE, Wu L, 
Ghorpade A (2003). Regulation of tissue inibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia. 
Glia 44: 47–56. 
27 Gardner J, Ghorpade A (2003). Tissue Inhibitor of Metalloproteinase (TIMP)-1: The TIMPed Balance of Matrix 
Metalloproteinases in the Central Nervous System. Journal of Neuroscience Research 74:801–806. 
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The illustration for these events (Fig. 1.1) shows the complexity of events 
involving TIMP-1 expression. A better understanding of the mechanism of this 
duality will lead to insights into development of new therapeutic options 
relevant to treatment of a variety of diseases involving neural injury. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 – Model for neuronal cells (astrocytes, microglia, and neurons) TIMP-1 regulation in 
acute (A) and chronic (B) inflammation proposed by Gardner & Ghorpade (2003). 
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The study of metalloproteinase and their endogenous specific inhibitors 
functions in the nervous system should open up new vision in CNS physiology 
and pathology. Actually, taking advantages of the increase on MMPs findings, 
these enzymes could be used as valuable tool to forecast cell behaviour and 
cell functional state. The broadly MMPs involvement in cell regulation 
mechanisms can be particularly helpful, to investigate, for instance, the effect 
of pharmaceutical drugs to be used in the treatment of several diseases, where 
MMPs might perform in an injurious manner.  
 
To highlight the link between ECM processing and neuronal development, the 
following section provides an overview of some aspects of the biological role of 
MMPs and their specific TIMPs in the nervous system. 
 
 
1.1 Matrix metalloproteinases and their endogenous inhibitors in the brain 
physiology: Brief review 
 
Extracellular matrix is the glue that maintains tissue integrity, and consequently 
the balance between its production and degrading is of vital importance. 
Cell-cell and cell-ECM interactions provide essential information for controlling 
tissue events. 
Matrix metalloproteinases (MMPs), an extracellular zinc-binding endopeptidase 
family, are instrumental in coordinating these interactions through the cleavage 
of ECM proteins and receptors28,29 and regulate extracellular signalling 
pathways by selectively exposing ECM cryptic sites and inducing proteolysis of 
non-ECM receptors and ligands30,31,32. These processes play a pivotal role during 
tissue growth and morphogenesis, such as during trophoblast implantation, and 
mammary and bone development33,3.  
                                                          
28 Werb Z (1997). ECM and cell surface proteolysis: regulating cellular ecology. Cell 91: 439–442. 
29 Nagase H, Woessner JF Jr (1999). Matrix metalloproteinases. J. Biol. Chem. 274: 21491–21494. 
30 McCawley LJ, Matrisian LM (2001). Matrix metalloproteinases: they're not just for matrix anymore. Curr. Opin. 
Cell Biol. 13: 534–540. 
31 Galko MJ Tessier-Lavigne M (2000). Function of an axonal chemoattractant modulated by metalloprotease 
activity. Science 289: 1365–1367. 
32 Hattori M, Osterfield M Flanagan JG (2000). Regulated cleavage of a contact-mediated axon repellent. 
Science 289: 1360–1365. 
33 Vu TH Werb Z (2000). Matrix metalloproteinases: effectors of development and normal physiology. Genes 
Dev. 14: 2123–2133. 
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The first MMP activity described belongs to a collagenase found in the tail of a 
tadpole undergoing metamorphosis34. To date, 25 different vertebrate MMPs 
have been identified, of which 24 are found in humans. 
They are designated by MMP1-28, however the names MMP4, MMP5 and MMP–
6 are no longer used, as the originally socalled members were subsequently 
found to be MMP2 or MMP335. The sequence homology with collagenase 1 
(MMP-1), the cysteine switch motif PRCGXPD in the propeptide that maintains 
MMPs in their zymogen form (proMMP), and the zinc-binding motif 
HEXGHXXGXXH in the catalytic domain are the signatures used to assign 
proteinases to this family. The exception is MMP-23, which lacks the cysteine 
switch motif. MMPs generally consist of a prodomain, a catalytic domain, a 
hinge region, and a hemopexin domain, as it is represented in Fig. 1.2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 – Domain structure of matrix etalloproteinases (MMPs). The domain organization of 
MMPs is as indicated: S, signal peptide; Pro, propeptide; CD, catalytic domain; Zn, active-site 
zinc; HD, hemopexin domain; FD, fibronectin domain; V, vitronectin insert; I, type I 
transmembrane domain; II, type II transmembrane domain; G, GPI anchor; Cp, cytoplasmic 
domain; Ca, cysteine array region; and Ig, IgG-like domain. A furin cleavage site is depicted as a 
dark grey band between propeptide and catalytic domain (adapted from Visse & Nagase, 
200336). 
 
                                                          
34 Gross J (1966). How tadpoles lose their tails. The journal of investigative dermatology. 47: 274-277. 
35Yong VW (2005). Metalloproteinases: Mediators of Pathology and Regeneration in the CNS. Nat Rev 
Neurosci. 6: 931-944. 
36 Visse R, Nagase H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, 
function, and biochemistry. Circ Res. 92(8):827-839. Review. 
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The most widely studied disease that involves MMPs is cancer, mainly in terms of 
invasion and metastasis formation. In this case, the tumour cell is thought to use 
MMPs to overcome multiple structural barriers and establish a new focus of 
growth at a distant site from the primary tumour mass. 
In the nervous system, MMPs have also been associated with pathogenesis, 
particularly in multiple sclerosis and malignant gliomas37. A growing literature 
has linked MMPs to stroke, to Alzheimer’s disease and to viral infections of the 
CNS. As mentioned above, 24 mammalian MMPs and 4 of their endogenous 
tissue inhibitors of metalloproteinases, TIMPs, act together to control tightly 
temporally restricted, focal proteolysis of ECM (Table 1.1).  
 
TIMPs are specific inhibitors that bind MMPs in a 1:1 stoichiometry. Four TIMPs 
(TIMP-1, TIMP-2, TIMP-3, and TIMP-4) have been identified in vertebrates38 and 
their expression is regulated during development and tissue remodelling. TIMPs 
(21 to 29 kDa) have an N- and C-terminal domain of ∼125 and 65 amino acids, 
respectively, with each containing three conserved disulfide bonds. The 
N-terminal domain folds as a separate unit and is capable of inhibiting MMPs36. 
TIMPs inhibit all MMPs tested so far, except that TIMP-1 fails to inhibit MT1-MMP39. 
Although each TIMP appears capable of inhibiting almost all MMPs, these 
proteins exhibit preferential inhibitory capacity. As the most described example, 
TIMP-1 and TIMP-2 can form a specific complex with the zymogens of MMP-9 
and MMP-2, respectively, through the C-terminal domain of each molecule40. 
 
On the basis of substrate specificity, sequence similarity, and domain 
organization, vertebrate MMPs can be divided into six groups: Collagenases, 
Gelatinises, Stromelysins, Matrilysins, Membrane-Type MMPs (MT-MMPs) and 
other MMPs. 
 
                                                          
37 Yong, VW, Krekoski, CA, Forsyth, PA, Bell, R, Edwards, DR (1998). Matrix metalloproteinases and diseases of 
the central nervous system. Trends Neurosci. 21: 75–80. 
38 Brew K, Dinakarpandian D, Nagase H (2000). Tissue inhibitors of metalloproteinases: evolution, structure and 
function. Biochim Biophys Acta. 1477:267–283. 
39 Will H, Atkinson SJ, Butler GS, Smith B, Murphy G (1996). The soluble catalytic domain of membrane type 1 
matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation: 
regulation by TIMP-2 and TIMP-3. J Biol Chem. 271: 17119–17123. 
40 Itoh Y, Ito A, Iwata K, Tanzawa K, Mori Y, Nagase H (1998). Plasma membrane-bound tissue inhibitor of 
metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell 
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Table 1.1 - Matrix metalloproteinase family members  
 
Member Name M latent/active 
(kDa)  
Collagen 
substrates 
Other ECM substrates 
MMP1 Collagenase-1 55/45 I, II, III, VII, VIII, X Agg, Gel, PG 
MMP2 Gelatinase-A 72/66 I, III, IV, V, VII, X, 
XI, XIV 
Agg, EL, FN, Gel, LN, 
PG, VN 
MMP3 Stromelysin-1 57/45 III, IV, IX, X, XI  Agg, EL, FN, Gel, LN, 
PG, VN 
MMP7 Matrilysin 28/19 IV, X Agg, Casein, EL, FN, 
Gel, LN, PG, VN 
MMP8 Collagenase 2 75/58 I, II, III, V, VII, 
VIII, X 
Agg, EL, FN, Gel, LN 
MMP9 Gelatinase B 92/86 IV, V, VII, X, XIV Agg, EL, FN, Gel, PG, 
VN 
MMP10 Stromelysin 2 57/44 III, IV, V, IX, X Agg, EL, FN, Gel, LN, 
PG 
MMP11 Stromelysin 3 51/44   
MMP12 Metalloelastase 54/45/22 IV Casein, EL, FN, Gel, 
LN, PG, VN 
MMP13 Collagenase 3 60/48 I, II, III, IV, VII, IX, 
X, XIV 
Agg, FN, Gel 
MMP14 MT1-MMP 66/56 I, II, III Agg, EL, FN, Gel, LN 
MMP15 MT2-MMP 72/60  Agg, FN, Gel, LN 
MMP16 MT3-MMP 64/52 III Gel, FN 
MMP17 MT4-MMP 57/53  Fibrinogen/fibrin 
MMP18 Collagenase 4 70/53 I  
MMP19 RAS I 1 54/45 IV Gel, FN, LN 
 
MMP20 Enamelysin 54/22  Amelogenin 
MMP21 Xenopus MMP 70/53   
MMP22 Chick embryo 
MMP 
51/42  Casein, Gel 
 
MMP23 CA-MMP41    
MMP24 MT5-MMP   Gel 
MMP25 MT6-MMP 34/2842 IV Gel, FN 
MMP26 Matrilysin 
2/endometase  
28/19  
 
 Gel 
MMP27 Human MMP22    
MMP28 Epilysin 56/45  Casein 
Agg (agrecan); Gel (gelatine); PG (proteoglicans); EL (elastin); FN (fibronectin); LN (laminin); VN (vitronectin) 
 
 
Collagenases43 (MMP-1, MMP-8, MMP-13 and MMP-18) that cleave interstitial 
collagens and other ECM and non-ECM molecules, Gelatinases (MMP-2 and 
MMP-9) that readily digest denatured collagen and contain three repeats of a 
                                                          
41 Pei D. (1999) CA-MMP: a matrix metalloproteinase with a novel cysteine array, but without the classic 
cysteine switch(1). FEBS Lett 457:262-70. 
42 Duanqing P (1999) Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in 
the leukocyte lineage Cell Research  9, 291-303. 
43 Lapiere ChM (2005). Tadpole collagenase, the single parent of such a large family. Biochimie. 87(3-4):243-7. 
Review. 
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type II fibronectin domain inserted in the catalytic domain, which bind to 
gelatin, collagens, and laminin44, Stromelysins45 (MMP-3 and MMP-10) that 
besides digesting ECM components, activate a number of proMMPs, 
Matrilysins46 (MMP-7 and MMP-26) that processes cell surface molecules such as 
pro-α-defensin, Fas-ligand, pro–tumor necrosis factor (TNF)-α, and E-cadherin 
besides ECM components. Membrane-Type MMPs that, with the exception of 
MT4-MMP, are capable of activating proMMP-2 and can also digest ECM 
components and other MMPs (MMP-11, MMP-12, MMP-19, MMP-20, MMP-22, 
MMP-23, MMP-28) are examples of MMPs that are not classified in the above 
categories.  MMP-11 is called stromelysin-3, but it is usually grouped with “other 
MMPs” because the sequence and substrate specificity diverge from those of 
MMP-3. MMPs are enzymatically activated by means of the cleavage of the 
propeptide47. Once activated, the MMPs are subject to inhibition by TIMPs. 
 
Activation of proMMPs by plasmin is an important pathway in vivo. Plasmin is 
generated from plasminogen by tissue plasminogen activator (tPA) bound to 
fibrin and urokinase plasminogen activator (uPA) bound to a specific cell 
surface receptor. Plasmin has been reported to activate proMMP-1, proMMP-3, 
proMMP-7, proMMP-9, proMMP-10, and proMMP-1348. Activated MMPs can 
participate in processing other MMPs. The stepwise activation system may have 
evolved to accommodate advanced regulatory mechanisms to control 
destructive enzymes, considering that TIMPs may interfere with activation by 
interacting with the intermediate MMP before it is fully activated36 (see Fig. 1.3). 
Nonetheless, MMPs activation can also occur either intracellularly by 
furin49,50,,51,52 (including MMP-11, the six MT-MMPs, MMP-23, and epilysin) or on 
the cell surface (the most revised example is proMMP-2 activation).  
                                                          
44 Allan JA, Docherty AJ, Barker PJ, Huskisson NS, Reynolds JJ, Murphy G (1995). Binding of gelatinases A and B 
to type-I collagen and other matrix components. Biochem J. 309:299–306. 
45 Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H (1990). Mechanisms of activation of tissue 
procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry;29:10261–10270. 
46 Uria JA, López-Otín C (2000). Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and 
showing the minimal domain organization required for secretion, latency, and activity. Cancer Res., 
60:4745-4751. 
47 Leppert D, Lindberg RL, Kappos L, Leib SL (2001). Matrix metalloproteinases: multifunctional effectors of 
inflammation in multiple sclerosis and bacterial meningitis. Brain Res Brain Res Rev. 36(2-3):249-57. Review. 
48 Lijnen HR (2001). Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost. 
86: 324-333. 
49 Pei D, Weiss SJ (1995). Furin-dependent intracellular activation of the human stromelysin 3 zymogen. Nature. 
375: 244–247. 
50 Sternlicht MD, Werb Z (2001). How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 
17: 463–516. 
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Figure 1.3 - The protease cascade for MMPs activation. uPA, urokinase plasminogen activator; 
tPA, tissue plasminogen activator  (adapted from: Van den Steen et al., 200153). 
 
 
Most proMMPs are secreted from cells and activated in the extracellular space. 
MT1-MMP-mediated activation of proMMP-2 has been studied extensively. The 
unique feature of proMMP-2 activation is that TIMP-2 is required to assist it54,55,56. 
As represented in Fig. 1.4, proMMP-2 forms a tight complex with TIMP-2 through 
their C-terminal domains, therefore permitting the N-terminal inhibitory domain 
of TIMP-2 in the complex to bind to MT1-MMP on the cell surface.  
The cell surface–bound proMMP-2 is then activated by an MT1-MMP that is free 
of TIMP-2. Otherwise, MT1-MMP linked to TIMP-2 can act as a “receptor” of 
proMMP-2. Effective activation of proMMP-2 is achieved when the ternary 
                                                                                                                                                                          
51  Marchenko GN, Strongin AY (2001). MMP-28, a new human matrix metalloproteinase with an unusual 
cysteine-switch sequence is widely expressed in tumors. Gene. 265: 87–93. 
52 Lohi J, Wilson CL, Roby JD, Parks WC (2001). Epilysin, a novel human matrix metalloproteinase (MMP-28) 
expressed in testis and keratinocytes and in response to injury. J Biol Chem. 276: 10134 –10144. 
53 Van den Steen P, Opdenakker G, Wormald M, Dwek R, Rudd P (2001). Matrix remodelling enzymes, the 
protease cascade and glycosylation. Biochimica et Biophysica Acta 1528: 61-73. 
54 Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI (1995). Mechanism of cell surface 
activation of 72-kDa type IV collagenase: isolation of the activated form of the membrane metalloprotease. J 
Biol Chem. 270: 5331–5338. 
11 Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d’Ortho MP, 
Murphy G (1998). The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and 
efficient activation of progelatinase A: a kinetic study. J Biol Chem. 273: 871–880.  
56 Wang Z, Juttermann R, Soloway PD (2000). TIMP-2 is required for efficient activation of proMMP-2 in vivo. J 
Biol Chem.; 275: 26411–26415.  
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complex of proMMP-2-TIMP-2–MT1-MMP is then presented to an adjacent free 
MT1-MMP for activation (interactions of MT1-MMP on the cell surface through 
hemopexin domains facilitates the activation process57). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 - Model of proMMP-2 activation by MT1-MMP and TIMP-2. Active MT1-MMP (MT-1) on 
the membrane binds a molecule of TIMP-2 (T-2), inhibiting its activity. MT1-MMP can form dimers 
or multimers on the cell surface through interaction of the hemopexin domains (HD). ProMMP-2 
(pMMP-2) subsequently binds to the C-terminal domain of TIMP-2 through its hemopexin domain. 
The second, active, MT1-MMP then cleaves the bait region of proMMP-2, thereby partly 
activating it. The MMP-2 dissociates from the membrane and is fully activated by intermolecular 
processing (adapted from Visse & Nagase, 200336). 
 
Considerable progress has been made in the understanding of biochemical 
and structural aspects of MMPs, including their activation and catalytic 
mechanisms, substrate specificity, and the mechanism of inhibition by TIMPs. 
Nevertheless, there are important questions that remain unanswered. In 
general, MMPs play critical roles in many normal growth and developmental 
aspects of tissue remodeling, wound healing, and angiogenesis, and in many 
pathological situations, are associated with cell migration, invasion, arthritis, 
and cancer tumour progression. MMPs carry out a myriad of biological 
functions by acting simply on ECM protein scaffold or by orchestrate cell 
behaviour handing out some biologically active molecules, such as growth 
factors.  
                                                          
57 Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M (2001). Homophilic complex formation 
of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J.; 
20: 4782–4793. 
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 As it can be attested by Table 1.2 examination, MMP-1 is responsible for cell 
activities such as cell migration or platelet aggregation while MMP-2 is 
associated with epithelial cell migration and promotes neurite growth. 
 
 
Table 1.2 - Biological Activities Generated by MMP-Mediated Cleavage  
 
 
Biological Effect 
 
 
Responsible MMPs 
 
Keratinocyte migration and 
reepithelialization 
 MMP-1 
Osteoclast activation  MMP-13 
Neurite outgrowth  MMP-2 
Adipocyte differentiation  MMP-7 
Cell migration  MMP-1,- 2, -3 
Cell migration  MT1-MMP 
Mammary epithelial cell apoptosis  MMP-3 
Mammary epithelial alveolar formation  MMP-3 
Epithelial-mesenchymal conversion 
(mammary epithelial cells) 
 MMP-3 
Mesenchymal cell differentiation with 
inflammatory phenotype 
 MMP-2 
Platelet aggregation  MMP-1 
 
 
Generation of angiostatin-like fragment 
 MMP-3 
MMP-7 
MMP-9 
MMP-12 
Generation of endostatin-like fragment  MMPs 
Enhanced collagen affinity  MMP-2, -3, -7, -9, -13 (but not 
MMP-1) 
Kidney tubulogenesis  MT1-MMP 
Release of bFGF  MMP-3, -13 
Increased bioavailability of IGF1 and cell 
proliferation 
 MMP-1, -2, -3 
MMP-11 
Activation of VEGF  MMPs 
Epithelial cell migration  MMP-2, MT1-MMP 
Apoptosis (amnion epithelial cells)  Collagenase 
Proinflammatory  MMP-1, -3, -9 
Tumor cell resistance  MMP-9 
Antiinflammatory  MMP-1, -2, -9 
Antiinflammatory  MMP-1, -2, -3, -13, -14 
Increased bioavailability of TGF-ß  MMP-2, -3, -7 
Disrupted cell aggregation and increased 
cell invasion 
 MMP-3, MMP-7 
Reduced cell adhesion and spreading  MT1-MMP, MT2-MMP, MT3-MMP 
Fas receptor–mediated apoptosis  MMP-7 
Reduced IL-2 response  MMP-9 
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1.1.1. MMPs in the physiology of the brain  
 
Matrix metalloproteinases and ADAMs (a disintegrin and metalloproteinase) are 
part of a larger family of structurally related zinc-dependent metalloproteinases 
called metzincins. As it has been mentioned above, structurally, MMPs are 
divided in three domains: an amino-terminal propeptide region, an 
amino-terminal catalytic domain, and a carboxy-terminal domain that is 
involved in substrate binding. ADAMs have a prodomain, a metalloprotease 
region, a disintegrin domain for adhesion, a cysteine-rich region, 
epidermal-growth-factor repeats, a transmembrane module and a 
cytoplasmic tail.  
The activity of MMPs is tightly regulated in several ways: at the level of 
transcription, by post-translational modifications such as proteolysis, and 
through the action of endogenous tissue inhibitors of metalloproteinases. The 
regulation of ADAMs is less well understood, although there is some evidence 
that the same three levels of regulation might control ADAM activity.  
MMPs and ADAMs have been implicated in neuroinflammation and multiple 
sclerosis, in the pathogenesis of malignant gliomas, and in other neurological 
conditions such as stroke, viral infections and Alzheimer's disease. In the case of 
ADAMs, their role in these pathological states has begun to be explored, but 
the available literature is still in its infancy. 
Although the well documented detrimental roles of metalloproteinases some of 
their functions in the CNS might be beneficial. For example, some 
metalloproteinases are expressed in the CNS during development, pointing to a 
possible role in brain maturation (appendix, Table 7.1, for details). 
Until now, gelatinases A and B (MMP-2 and MMP-9) have been the most 
frequently investigated MMPs in the brain. MMP-2 mRNA, protein, and 
enzymatic activity have been detected in various brain structures and reported 
to be preferably astroglial in origin58,59,60,61,62,63,64. In addition, Planas and 
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co-workers65 found MMP-2 also in some cortical neurons, and neuronal MMP-2 
has also been described in the cerebellum, including the Purkinje neurons62,63,66. 
A potentially functional role of MMP-2 in post-lesion axonal sprouting and 
neuronal plasticity has been suggested by Reeves and colleagues, who 
reported that differentiation and functional plastic recovery of the entorhinal 
cortex projections to the hippocampal dentate gyrus are associated with 
increased MMP-2 activity, and that MMP inhibitor FN-439 prevents recovery67,68. 
In contrast to MMP-2, MMP-9 mRNA and protein expression59,69,70 as well as its 
activity59,62,63,69,71 have been detected in the hippocampus, cerebellum and 
cortex, predominantly in neurons. MMP-9 (at the protein and enzymatic activity 
levels) has been found mainly in cell bodies and dendrites58,65. Furthermore, in 
vitro studies showed MMP-9 protein expression in the neuronal processes of 
cultured hippocampal neurons58. A more limited level of MMP-9 expression has 
also been observed in glia, in particular in astrocytes and microglia, both in vivo 
and in vitro72. Szklarczyk and co-workers58 and Zhang and collegues63 have 
shown that kainic acid (KA) treatment results in upregulation of MMP-9 mRNA, 
protein and enzymatic activity in hippocampal dentate gyrus and neocortex 
early after seizures (6–24 h). The exclusive hippocampal localization of MMP-9 
upregulation within the dentate gyrus suggests MMP-9 involvement in synaptic 
plasticity. Most interestingly, the enhanced mRNA expression was observed 
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both in the neuronal cell bodies as well as in the dendritic layer, implying an 
activity-driven translocation of the MMP-9 mRNA72.  
Furthermore, MMP-9 mRNA expression levels were increased after 
KCl-depolarization in the cortex72,73. Enzymatic activity of MMP-9 was found to 
be elevated in the rat hippocampus and prefrontal cortex in the course of 
spatial learning66, differing from MMP-2 activity. On the other hand, MMP-9 
mRNA level decreases in the cerebral cortex after sleep deprivation whereas 
after enhanced ambient temperature, a condition that promotes sleep, it 
increases70. During postnatal cerebellar development, MMP-9 is expressed by 
granule and Purkinje neurons of the cerebellum. MMP-9 promotes cerebellar 
granule cell migration and axonal growth during early postnatal life71. 
In vivo studies of MMP-9-deficient mice revealed abnormal accumulation of 
granular precursors in the external granular layer at a time when migration is 
normally extensive. Furthermore, granular precursor migration was delayed and 
their programmed cell death was reduced in MMP-9-deficient mice, suggesting 
that MMP-9 is involved in the control of granule cell migration and apoptosis. 
These results provide direct evidence for a physiological role of MMP-9 in 
neuronal precursor migration and apoptosis in the developing cerebellum, and 
emphasize the importance of MMP-9 in the temporal regulation of the 
cerebellar microenvironment. These results suggest a potencial   connection(s) 
between neuronal survival, synaptogenesis and MMP-9 since it has been shown 
a close association of MMP-9 expression with neuronal physiology. Apparently, 
no functional data have been reported specifically on MMP-9 and neuronal 
plasticity, despite the availability of MMP-9 knockout mice. Those animals were, 
however, used for brain damage studies, and it has been found that lack of 
MMP-9 reduces the neurodegeneration evoked by either ischemia or brain 
trauma35,74,75,76. This notion appears surprising in the context of the previously 
described data implicating MMP-9 in neuronal plasticity. Recently, Wang & 
Tsirka provided evidence that MMP-9 may play a deleterious role in acute brain 
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injury within the first 3 days after intracerebral haemorrhage and that blockade 
of MMP activity during this critical period may have efficacy as a therapeutic 
strategy for the treatment of acute brain injury77. However, although under the 
variety of neurodegenerative conditions (ischemia, brain trauma, viral 
infections, amyotrophic lateral sclerosis, Parkinson’s disease, Alzheimer’s 
disease) MMP-9 still remains mainly neuronal in origin, it is not clear whether it is 
expressed by the neurons prone to death and/or by those attempting to 
recover from the damage37,59,74,75,76,77,78,79,80. Other MMPs, such as MMP-25 
(MT5-MMP) and MMP-3 (stromelysin-1) have been described by several 
researchers. Nevertheless their specific role in brain physiology remains to be 
elucidated.    
Scheme A of Fig. 1.5 represents MMP-9 activation72, showing several regulation 
steps. There are a number of gene regulatory sequences driving the MMP-9 
expression. The transcription factors activator protein-1 (AP-1) and nuclear 
factor-κB (NF-κB) are the most prominent. Once produced, the MMP-9 mRNA is 
subjected to regulation at its stability level by nitric oxide (NO); as well it can 
apparently be translocated in neurons towards activated dendrites. Notably, 
MMP-9 contains ARE-like sequences that have been suggested to be of pivotal 
importance for the translocation in other messages. The protein is synthesized 
with the signal peptide responsible for a translocation to the endoplasmic 
reticulum, where the signal peptide is removed. Glycosylation of MMP-9 protein 
provides an additional level of regulation. The next step is an export of MMP-9 
protein, in vesicles, to the extracellular space. The MMPs are produced by cells 
in an inactive form (pro-MMP) where the cystein residue of the propeptide 
region is bond to a zinc atom present in the catalytic domain. 
Fully active protein is produced by disruption of the cysteine–zinc interaction 
and enzymatic removal of the propeptide. The activation of the pro-enzyme is 
controlled by a cascade of steps involving other MMPs and the plasmin system. 
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Figure 1.5 – (A) Schematic representation 
of MMP-9 activation (A2RE, A2 response 
element; AP-1, activator protein-1; ER, 
endoplasmic reticulum; LRP, low-density 
lipoprotein receptor-related protein; NF-κB, 
nuclear factor-κB; NO, nitric oxide; tPA, 
tissue plasminogen activator; uPA, 
urokinase plasminogen activator; uPAR, 
uPA receptor (B) The network of 
MMPs/TIMPs, sheddases and their 
modulatory molecules as target of MMP 
inhibitors. (adapted from Dzwonek J et al., 
200472).  
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Tissue type plasminogen activator (tPA), as well as urokinase type plasminogen 
activator (uPA) are principal enzymes releasing active plasmin that activates 
MMP-1 and MMP-3, which in turn can cleave pro-MMP-9. Interestingly, tPA can 
act on MMP-9 also in a plasmin-independent manner, namely it has been 
shown that tPA can bind to the low-density receptor related protein (LRP) and 
indirectly regulate MMP-9 gene transcription. LRP can also act as a receptor for 
MMP-9 that mediates internalization and degradation of the enzyme. Finally, 
MMP-9 activity can be inhibited by TIMPs. 
Scheme B (Fig. 1.5) represents the network of MMPs/TIMPs and their modulatory 
molecules as target of MMPs inhibitors. TIMPs and MMPs are regulated by ECM 
components, cytokines and growth factors. The effect of this regulation may 
display a cascade of proteolytic events that ends with the degradation of the 
ECM. TIMPs have special role by blocking MMPs activity and, consequently, 
inhibiting matrix destruction. 
This example illustrates the complexity and the widespread of the potential 
events that may occur during physiological and pathological cell 
development. 
 
 
1.1.2. TIMPs in the physiology of the brain 
 
All four TIMP genes have been shown to be expressed in unstimulated 
brain81,82,83 (appendix, Table 7.2, for details). TIMP-1 mRNA and protein have 
been found to be present in the hippocampus83. TIMP-1 mRNA expression was 
also described in cortical neurons73 and in the cerebellum84, where Villant and 
co-workers85 have found TIMP-1 protein in the cell bodies of interneurons, 
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Purkinje cells and Bergman glia. Nedivi and colleagues86 were the first to find 
increased levels of TIMP-1 mRNA in the hippocampal dentate gyrus following 
seizures. Rivera and co-workers83 and Jaworski and collegues87 extended this 
observation, by documenting elevated TIMP-1 mRNA and protein expression in 
all of the hippocampal subfields, thus suggesting that it is a neuronal response 
to the enhanced activity. Furthermore, Rivera and co-workers83 found that 
seizures elevate TIMP-1 immunoreactivity in neuronal cell bodies and dendritic 
areas at early stages after seizures and in astrocytes 3 days after seizures, when 
the reactive gliosis is present (as result of neuronal death and consequent 
formation of a dense fibrous network of neuroglia in areas of damage). Gertten 
and colleagues73 have shown that expression of TIMP-1 mRNA increases in 
cortical neurons after KCl-depolarization. Robust induction of TIMP-1 mRNA has 
been observed after acute electroconvulsive seizures in neurons of the dentate 
gyrus of the hippocampus and the outer layer of the cerebral cortex72. In 
pathological conditions of brain damage evoked by ischemia as well as viral 
infections, elevation of TIMP-1 expression has also been noted and suggested 
to have a neuroprotective potential72,76,77. It is also of great interest that TIMP-1 
gene expression in the hippocampus is regulated by AP-1 transcription factor, 
whose association with neuronal plasticity, including learning and memory, has 
been very extensively documented72,87. Even though, the possible function of 
TIMP-1 in the brain is concerned, very little is known. However, it should be 
noted that this protein delivered in an adenoviral vector was capable of 
inhibiting excitotoxic cell death in cultured neurons88. The action of TIMP-1 was 
anti-necrotic rather than anti-apoptotic as it was very fast (already within 1h) 
and specific to glutamate evoked neuronal loss, but not effective against 
chemical induced ischemia or nerve growth factor withdrawal. Furthermore, 
blocking MMP activity using synthetic MMP inhibitors as well as treatment with 
TIMP-3 offered no neuroprotection against excitotoxicity88. The possible 
mechanism of TIMP-1 neuroprotection involves its ability to lower intracellular 
calcium levels in response to glutamate. TIMP-2 is the most abundantly 
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expressed TIMP in the adult CNS84. In the rat cerebellum both the mRNA and 
protein are present in cell bodies of interneurons, Purkinje cells and granular 
neurons in the internal granular layer85. In the cortex, expression of TIMP-2, 
mRNA is observed predominantly in neurons72,73. Notably, TIMP-2 expression 
appears to be upregulated neither by neuronal depolarization nor by 
pathological conditions that activate TIMP-179. TIMP-3 is expressed at the lowest 
level in the adult rat brain84, although its mRNA has been found in the cortex89, 
cerebellum85, thalamus, olfactory bulb84, and brain stem (composite 
substructure of the brain that includes the midbrain, the pons and the medulla 
oblongata)83.  
Immunohistochemistry has shown cerebellar TIMP-3 expression in the dendritic 
elongations of Purkinje cells and in the granular neurons in the internal granular 
layer. In contrast, TIMP-3 mRNA was only detected in the cell bodies of Purkinje 
cells. During viral infections there is TIMP-3 mRNA and protein upregulation in 
neurons within hours90. TIMP-3 protein is produced by primary cultures of cortical 
neurons91 and astrocytes92. Functionally, it has been shown that TIMP-3 may 
play a proapoptotic role in a model of neuronal cell death evoked by 
doxorubicin91. The least is known about TIMP-4 expression in the brain. TIMP-4 
mRNA is present in the cerebellum, cerebrum (telencephalon) and brain 
stem84. 
MMPs are effectors of blood brain barrier opening and invasion of brain 
parenchyma by immune cells in multiple sclerosis and brain metastasis. In 
addition they can act, together with related metalloproteinases, as enhancers 
of the immune response via their proteolytic release of membrane-bound 
cytokines and their receptors. Hydroxamic acid type MMP-inhibitors have been 
used successfully in animal models of multiple sclerosis and brain metastasis to 
attenuate acute disease symptoms and structural damage of the brain 
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parenchyma93,94; in brain metastasis they were able to attenuate 
postmeningitidal cognitive deficits. A large number of potent inhibitors have 
been discovered and some have been tested in clinical trials as therapies for 
cancer and arthritis with great expectations95. Although many of these 
experiments were discontinued, a few MMP inhibitors are still undergoing 
clinical trials. Most preclinical studies have focused on the role of MMPs in the 
early stages (progression and metastases) of cancer, in which MMP inhibition 
seems to have its greatest effect. Unfortunately, clinical trials of MMP inhibitors 
were conducted almost uniformly in patients with advanced, metastatic 
disease, and all have failed to show any beneficial effect on patients. It is 
possible that these same trials could have had different outcomes if they were 
conducted in patients with earlier stages of disease. The use of this novel group 
of compounds in human diseases requires a better understanding of the array 
of MMPs involved in the pathogenesis of a specific disease and the design of 
inhibitors with the respective specific target profile. Although not treating a 
primary cause of disease, their disease-modifying properties make them 
primary candidates for adjuvant and symptomatic therapy in multiple sclerosis 
and brain metastasis, respectively96. 
 
1.1.3 MMPs target molecules in the brain ECM 
The ECM is composed of secreted glycoproteins and proteoglycans that form a 
network to which cells adhere. In the CNS this network accounts for upwards 
20% of the total volume and consists predominantly of the proteins fibronectin, 
laminin, vitronectin, thrombospondin, tenascin, and collagen IV97. 
The ECM transmits signals from cells to the ECM and vice versa and integrins 
have a central role in these signalling pathways98.  Over the past few years, 
evidence has emerged that integrins are crucial to brain development, 
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performing more than just adhesion molecules, they exert control over various 
signalling pathways to regulate virtually every aspect of cell behaviour.  
This so-called “perineuronal net” appears to provide physical support, regulate 
ionic and nutritional homeostasis of surrounding cells, and possesses ligands that 
interact with cell surface receptors that initiate signalling events designed to 
guide a wide range of functions including cellular proliferation, motility, 
differentiation, neurite outgrowth, growth cone targeting, synapse stabilization, 
and apoptosis97,99,100. 
MMPs seam to process their substrates following a peculiar manner; it is not 
clear what restrictions may modulate substrate recognition and activity. There 
are virtually no well documented physiological MMP target proteins, but several 
of pathological ones. Recently, in the context of ECM the expression “cryptic” 
(from the Latin word crypticus and the Greek word kryptikos) refers to functional 
sites that are buried inside the structure of the ECM macromolecules. Activation 
of these cryptic ECM activities requires structural modification, which can occur 
by conformational change or proteolytic processing. The chief enzymes that 
cleave matrix components, exposing these cryptic sites, are the MMPs. 
Yet the brain is largely devoid of classical basement membranes – it does, 
however, have extracellular matrix molecules101.  
Thus, MMPs are important components in many biological and pathological 
processes because of their ability to degrade ECM components. It has become 
clear that ECM is not a mere scaffold for cells but that it also harbours cryptic 
biological functions that can be revealed on proteolysis. This puts a new light on 
the interplay between cells, the ECM, and its catabolism. In the neurons of the 
brain several components of the TIMP/MMP system are expressed and are 
responsive to changes in neuronal activity. Furthermore, functional studies, 
especially involving blocking of MMP activities, along with the identification of 
MMP substrates in the brain strongly suggest that this enzymatic system plays an 
important physiological role in adult brain neurons, possibly being pivotal for 
neuronal plasticity.  
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1.2 Cell culture  
1.2.1 Types of cell cultures 
 
The most truthfully and viable way to assess signalling pathways and regulation 
mechanisms of cell biology is throughout skills involved in cell culture. Cell 
culture has been widely used as an essential tool in molecular biology, 
toxicology and biotechnology, to address important technical and economical 
aspects of biology. There are three varieties of cultured cells - primary cultures, 
cell strains and cell lines - that will be succinctly described in the next 
paragraphs. It will be emphasised the advantageous aspects of each type of 
culture.   
Primary culture is derived either by outgrowth of migrating cells from a fragment 
of tissue or by enzymatic or mechanical dispersal of the tissue. Regardless of the 
method employed, this is the first in a series of selective processes that have 
might untimely give rise to a relatively uniform cell line. In primary explantation 
selection occurs by virtue of the cells capacity to migrate from the explant 
while with dispersed cells, only those cells that survive the disaggregation 
technique and adhere to the substrate or survive in suspension will form the 
basis of a primary culture. The preparation of primary cultures is labour intensive 
and they can be maintained in vitro only for a limited period of time. During 
their relatively limited life span primary cells usually retain many of the 
differentiated characteristics of the cell in vivo, which allows a more closely 
prediction of reality cell behaviour of physiological or pathological states102.  
If the primary culture is maintained for more than a few hours, a further 
selection step will occur. Cells capable of proliferation will increase, some cell 
types will survive but not increase, and yet others will be unable to survive under 
particular conditions used. Hence, the relative proportion of each cell type will 
change and continue to do so until, in the case of monolayer cultures, all the 
available culture substrate is occupied. Primary cultures are derived directly 
from the tissue of a living organism.  The development of this technique in the 
early 20th century by Harrison103,104,105,106 marked the first experiments using 
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cultured cells. In fact, in 1910 in a single stroke Harrison invented the method of 
tissue culture, and then used it to prove the neuron doctrine105. In these 
experiments, explants of tissue from spinal cord of a frog embryo were 
incubated in lymphatic fluid.  After a day in culture, light microscopy was used 
to observe that the neurons sprouted axons.   
Cell strains are derived from primary cultures by dissociating the cells from one 
another and plating them onto plastic tissue culture dishes.  This type of culture, 
also called continuous culture, is comprised of a single cell type that adheres to 
the dishes and grows and divides when incubated in media. Many cell strains 
retain the differentiated properties characteristic to their tissue of origin.  Cell 
strains can be serially propagated in culture either for a limited number of cell 
divisions (approximately thirty) or otherwise indefinitely. 
Cell lines consist in a population of cultured cells that have undergone genetic 
changes that allow them to divide indefinitely – i.e. cells have become 
“immortal”. Continuous cell lines that can be propagated indefinitely generally 
have this ability because they have been transformed into tumour cells. Tumour 
cell lines are often derived from actual clinical tumours, but transformation may 
also be induced using viral oncogenes or by chemical treatments. Transformed 
cell lines present the advantage of almost limitless availability, but the 
disadvantage of having retained very little of the original in vivo characteristics. 
 
 
1.2.2 Cell culture scene – the therapeutic and technological challenges 
in neuroscience 
 
Considering 1.5 kilograms of flaccid matter, elaborated folds, about 100 billion 
neuronal components, hundreds of trillions of interconnections, many thousand 
kilometres of cabling… The brain is often described as the most complex system 
in the universe. The task for neuroscientists is to assess how complexity can help 
scientific community to better understand the mechanism of nervous systems107.  
                                                                                                                                                                          
105 Harrison RG. 1910. The outgrowth of the nerve fiber as a mode of protoplasmic movement. J Exp Zool 
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Cultured neurons artificially prevented from expressing a natural dynamic 
behaviour can rapidly modify their molecular makeup and revert to their 
original activity pattern108. Synaptic properties also are bafflingly varied. 
Chemical synapses show a host of plastic phenomena whose time-courses 
span at least nine orders of magnitude, from milliseconds to weeks, providing a 
substrate for learning and memory107. 
In summary, no brain, however small, is structurally simple. The establishment of 
primary cell cultures is invaluable for studying cell and molecular biological 
questions. A variety of human cell lines exist, however, as described above, 
most have acquired significant genetic alterations from their cells of origin, 
including deletion of important regulatory genes. Therefore is important to 
create new methods to ascertain natural cell behaviour.   
Presently, cell culture investigation, on the neuroscience field, have as primary 
propose to elucidate cell death mechanisms involved in acute cellular injury, 
necrosis, and programmed cell death to improve neuronal transplantation 
methodology, as well as in the development of therapeutic strategies for 
neuroprotection/neurorepair for patients with neurodegenerative diseases109.  
Although exciting, there are certain drawbacks to therapeutic possibilities 
based on organ/tissue transplantation. One of the most serious might be the 
immune response to foreign tissue, even when anti-rejection drugs are 
available, as they can have severe side-effects in certain patients. In 1998 the 
world woke up to the discovery that human embryonic stem (hES) cells could 
be grown in culture. A research group from Geron Company, published in 
Science110 that they had successfully cultured hES cells and that these cells 
could originate all the major tissue types of the body. These new findings allow 
the removal of adult stem cells from patient under treatment, expand these in 
the culture plate, genetically modify them, and finally transplant them back. 
Another important discover in neurological field, that opened the perspectives 
for overlap many degenerative diseases, was made by Kempermann and 
Gage111. In 1999, they found dividing cells in the human adult brain, that can 
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grow in the culture dish. The idea of using cells rather than whole organs to 
alleviate disease has led to the term “cell therapy”. Presently, the major 
problem persists:  the origin of the cell. By combining genetics with cell biology 
scientific community controls life process, getting closer to playing God. This 
scenario will throw up some of the most important philosophical, moral, ethical 
and theological questions. Clearly, cell biology could deliver therapy for many 
illness people, and may contribute to future discoveries regarding human 
health, but in the process of generating human embryos or continually replace 
body tissues will open a Pandora’s box of ethical and moral issues. 
Together bioethical concepts and technological challenges have provided 
alternative routes on cell-based therapies for human brain disease.  
Feron and his research team (2005112) demonstrated the feasibility of taking a 
nasal biopsy and reliably generating enough cells in culture for transplantation 
within 4 weeks as therapeutic strategy. They concluded that transplantation of 
autologous olfactory ensheathing cells into the injured spinal cord is feasible 
and is safe up to one year post-implantation. 
Similarly, Westerlund and co-workers (2005113) stated that it may be feasible to 
produce neural tissue for autotransplantation from endoscopically harvested 
stem cells, but further work is needed in refining culture protocols to control 
phenotype fate. These recent observations sustain the development of new 
protocols of cellular isolation and culturing that, consequently improve cell 
yield, viability and recover. 
 
 
1.2.3. Enzymes used for brain disaggregation  
 
1.2.3.1 Trypsin 
 
A. General considerations 
Trypsin is a prominent member of the serine protease family, and forms the 
functional principle of some large and highly specific proteases, involved in 
processes ranging from digestion to key regulatory mechanisms such as 
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coagulation and hormone release, that serve to maintain a favourable 
extracellular environment114. 
Trypsin is an endopeptidase, i.e. cleavage occurs within the polypeptide chain 
rather than at the terminal amino acids located at the ends of polypeptides. 
This pancreatic serine protease specifically cleaves at the carboxylic side of the 
positively charged lysine and arginine residues115. Restrictions to the specificity 
of trypsin occur when proline is at the carboxylic side of lysine or arginine; the 
bond is almost completely resistant to cleavage by trypsin. Cleavage may also 
be considerably reduced when acidic residues are present on either side of a 
potentially susceptible bond116. Trypsin is derived from trypsinogen, the inactive 
precursor zymogen of trypsin, after enzymatic removal of an N-terminal 6-amino 
acid leader sequence resulting in the 23.8 kDa trypsin molecule. The optimum 
pH is 8.0 and it migrates as a single band on SDS-PAGE. Trypsin is inhibited by 
organophosphorus compounds such as diisopropylfluorophosphate and by 
natural inhibitors from pancreas.  Soybean, lima bean, and egg white are also 
sources of natural inhibitors117,118.   
After its production in the pancreas, trypsin is transported to the small intestine, 
where begins the digestion of proteins to polypeptides and amino acids. Trypsin 
is an autocatalytic enzyme; that is, it catalyses the conversion of trypsinogen to 
trypsin although a small amount of another enzyme, enterokinase, is required to 
catalyze the initial reaction of trypsinogen to trypsin. 
This pancreas-derived enzyme has been increasingly applied for protein 
sequencing, mapping and structure studies. For these kinds of applications, 
where the specificity of cleavage is exceptionally important, trypsin is often 
modified by TPCK, tosyl phenylalanyl chloromethyl Ketone, which will inactivate 
chymotrypsin (that is frequently present in trypsin solutions).  
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B. Trypsin in cell culture 
Trypsin is commonly used for the dissociation and disaggregation of 
anchorage-dependent mammalian cells and tissues, being extensively used in 
the laboratorial experiments to re-suspend cells adherent to the petri dish wall 
during the process of harvesting cells. The concentration of trypsin necessary to 
dislodge cells from their substrate is dependent primarily on the cell type and 
the age of the culture. Although treatment of cells with trypsin does not affect 
cellular viability to any great extent, trypsinization has been reported, since 
1970s119, to alter certain properties of the cell, including modification of 
adhesive properties, liberation of glycoproteins and sugars from the cell 
surface, among other effects that conditioned cell recover. The concentration 
of trypsin necessary to dislodge cells from their substrate is dependent primarily 
on the cell type and the age of the culture. 
Autolysis constitutes the main inconvenient for trypsin usage in the laboratory. 
To minimize this problem users are encourage to store trypsin at cold 
temperatures (between −20 and −80ºC). Another way of preventing trypsin 
self-cleavage is storage at pH 3. Activity is restored when the pH is adjusted 
back to pH 8.  
Some aspects of trypsin activity are far to be overcome, for instance the low 
reproducibility of the commercial batches, witch can compromise the correct 
interpretation of experimental results.  
 
 
1.2.3.2 Aspartic proteinases from Cynara cardunculus L.  
 
Cardosins are aspartic proteinases (EC 3.4.23) isolated from the inflorescences 
of Cynara cardunculus L., whose milk-clotting activity has been exploited in 
Portugal in the manufacture of traditional cheeses since the Roman era. 
Faro and co-workers120 showed that the clotting activity of the aqueous extract 
of C. cardunculus pistils is due to the presence of an acid proteinase. Further 
studies revealed that the enzymatic extract is heterogeneous and that it 
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contains different aspartic proteinases, cardosin A0121, cardosin A and 
cardosin B122,123.  
Although, most of the biological functions proposed for cardosins are still 
speculative, cardosin A was shown to be highly expressed in the stigmatic 
papillae and to contain an Arg-Gly-Asp (RGD) motif which is a well known 
integrin-binding sequence allowing to suggest that this enzyme may participate 
in an RGD-dependent proteolytic mechanism in pollen–pistil interaction124,125. 
The specific localization of cardosin B in the stylar transmitting tissue also 
suggests that this enzyme may be involved in the remodelling and/or 
degradation of the pistil extracellular matrix during pollen tube growth126. 
Hence, it is possible that cardosins may fulfil important roles during the sexual 
reproduction of the plant. 
Cardosin A0, cardosin A and cardosin B are active at pH values between 2 and 
7 with the maximum of activity determined to be close to pH 5. This 
characteristic, along with the fact that diazoacetil norleucine methyl ester 
(DAN) and pepstatin A inhibits both of them, clearly indicates that, as 
mentioned above they belong to the class of aspartic proteinases. Pepstatin 
inhibition constants are 3nM for cardosin A and less than 1nM for cardosin B123. 
Cardosins are two-chain glycosilated enzymes, which are though to have 
arisen by gene duplication123. 
They are synthesized as single-chain zymogens, and subsequently converted 
into two-chain mature enzymes127,128. The sequence alignment of cardosins A 
and B suggests that processing of the single-chain precursor, to produce the 
two-chain enzyme, is likely to occur through the cleavage of two peptide 
bonds, resulting in the removal of a region whose sequence is specific for plant 
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aspartic proteinases (PSI). This sequence, of about 100 amino acids, is present 
only in plant aspartic proteinases and bears no sequence similarity with aspartic 
proteinases of microbial or mammalian origin and its removal constitutes a 
crucial step in the regulation of cardosins activity.  
Although they cleave preferably peptide bonds between residues with bulky 
hydrophobic side chains, cardosins B displays a broader specificity and a 
higher proteolytic activity123,129130. This has been demonstrated, for example, by 
Ramalho-Santos and colleagues in 1996. These studies pertaining to the 
independent action of cardosins A and B toward bovine caseins, made it clear 
that in αs1-casein the two enzymes cleave, first, the bonds Phe23-Phe24, 
Phe153-Phe154 and Trp164-Tyr165. Cardosin A also cleaves the bond Tyr165-Tyr166, 
whereas cardosin B cleaves an extra type of bond, Phe150-Arg151, revealing a 
slightly broader specificity129. Simões, 1998 developed similar work with β-casein 
and the differences on cardosins specificity were confirmed. 
 
Several studies have been developed concerning their physicochemical 
characterisation. At the present the tree-dimensional structure of cardosin A is 
solved131 and a large amount of information concerning its activity and 
specificity is available. Furthermore, cardosin A has been characterized 
regarding catalytic and specificity aspects in non conventional 
environments132,133 and concerning its thermal stability using biophysical 
approaches134.  
 
A recent investigation has demonstrated that cardosin A cleaves collagen 
within the triple helix (Fig. 1.6), following a well defined pattern of hydrolysis that 
is maintained for at least 24 hours of digestion (as shown in Fig. 1.7-A), 
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suggesting that cardosin A can hydrolyse collagen at a small number of 
specific peptide bonds. N-terminal sequencing of hydrolysis products allowed 
the identification of one cleavage site as being Phe464-Gln465 in the α2 chain of 
collagen135. Cardosin A shows collagenolytic activity, directed within the helical 
region, hitherto believed to be resistant to all non-mammalian proteinases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 – Schematic representation of collagenolytic activity of cardoisn A (green arrows). The 
cleavage bond F464-Q465 of alpha 2 of collagen type I was determined by sequence analysis. The 
traditional fragments TCA and TCB produced by collagenases are generated through cleavage 
at Gly775-Leu/Ile776 bonds of triple helices (red arrow).  (adapted from Duarte et al., 2005135) 
 
 
 
It was additionally demonstrated, that cardosins A0 and B can also hydrolyse 
human type I collagen136. The pattern of type I collagen hydrolysis by cardosins 
are shown in Fig. 1.7. It is possible to visualise the wide specificity of cardosin B 
towards collagen molecule, given that fragments produced at early incubation 
times are subsequently digested, in contrast to cardosins A0 and A 
performance. 
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Figure 1.7 – Human type I collagen hydrolysis pattern generated by cardosins A0, A and B 
(C: indigested collagen; 1, 8, 24 and 48 stand for incubation times in hours). Arrows represent the 
two subunits of each respective enzyme. (adapted from Duarte, 2001136) 
 
 
It was also shown, by using an animal model of intestinal adhesion produced by 
normal surgical procedures within the abdominal cavity, that immobilised 
cardosin A reduces the amount of fibrotic tissue that is formed after surgical 
intervention137.  
Concerning cardosin A0 and cardosin B there is still little information but it is 
slowly being build up. At the present, a detailed characterisation of cardosin A0 
is being carried out. It is known that cardosin A0 is in fact a heterogeneous 
mixture of enzymes that, on the contrary to what was thought until now, exhibit 
high proteolytic activity121. 
A simple purification protocol for these proteinases was developed and 
includes an acidic extraction followed by gel filtration and ion exchange 
chromatography123. Recently, the previously existent purification method was 
modified in order to achieve accurate and faster cardosins purification132.  As 
represented in Fig. 1.8 cardosins mixture obtained by size-exclusion 
chromatography is further purified by ion-change chromatography to obtain 
cardosins A0, A and B in an approximated proportion of 54, 41 and 5% of total 
protein in the fraction obtained by size-exclusion chromatography. 
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Figure 1.8 – Simple representation of cardosins purification protocol. The red arrow in size 
exclusion chromatogram identifies the fraction corresponding to cardosins mixture that is 
subsequently applied to ion change resin to obtain cardosins A0, A and B. 
 
 
Furthermore, cardosins account for more than 60% of the total protein content 
in mature stigmas and are the first example of extremely abundant proteinases 
in higher plants. In this way, together they account for the majority of the 
soluble protein in mature pistils, which allows their purification in a large scale.  
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The chromatographic fraction signalled by a red arrow in Fig. 1.8, compromise 
the three complementary activities from C. carduncullus L. acidic extract that 
could be used as an inexpensive and well defined enzymatic tool for several 
applications. In addition to the characteristics mentioned above, namely in 
what concerns their specificity, this feature supports the implementation of a 
new protocol for the establishment of primary cultures of neurons that uses 
cardosins as enzymes for cell disaggregation. 
As cited beyond collagen type IV, laminins vitronectin and fibronectin are 
typical components of brain extracellular matrix. Some sequences of these 
ECM proteins were analysed with regard to the known primary specificity for 
cardosins and several hypothetical cleavage sites were selected and 
compared with the cleavage of specific peptide bonds for trypsin (Appendix, 
Fig. 7.1-7.5, for sequence examination). Even though knowing that tertiary and 
quaternary structure of this proteins might be hiding the selected peptide 
bondes,  a straightforward observation of their sequences reveal that there are 
less target peptide bonds for cardosins then for trypsin, which could be 
particularly useful for cell integrity preservation during brain disaggregation with 
cardosins. 
Since, for cell isolation there is a need to cut cell-cell and cell-ECM interactions 
minimizing damage to individual cells, it is auspicious to take advantage from 
the narrow specificity of these proteolytic enzymes. 
 
 
 
  
 
 
2. Aims 
2. Aims 
 
2. Aims of the present study 
 
 
The main objective of this research is to evaluate cell behavior after isolation 
from brain tissue using cardosins in place of trypsin for brain disaggregation. 
 
After neuronal primary cultures establishment from rat cortical brain, neuronal 
viability of the cultured cells over a 7 days period will be assessed. 
To accomplish this task, it will be adopted a multi-modal approach, that 
includes the traditional methodologies for viability determination (MTT reduction 
assay & Tripan Blue staining) combined with other strategies. These comprise, 
for instance, morphological evaluation by immunocytochemistry and the 
employment of molecular methods to determine protein expression. 
 
The scheme described beyond, will be further used to evaluate cell recover 
after mechanical lesion in neuronal cultures, mainly, regarding neuritogenesis 
re-expression. 
 
In addition, in the frame of this study, it will be particularly interesting to establish 
a relationship between neuronal development and MMPs expression, given 
that these ECM-degrading proteases, play important roles in the cellular 
response to several environmental stimulus.   
 
 
 
 
  
 
 
3. ESTABLISHMENT OF NEURONAL 
PRIMARY CULTURES 
3.Establishment of neuronal primary cultures 
3. Establishment of neuronal primary cultures 
 
3.1. Brief introduction 
 
The properties of individual cells are difficult to study in the context of a 
multi-cellular organism.  To avoid this difficulty, researchers study cells growing in 
culture.  The two major advantages are the control of physiochemical 
environment (pH, temperature, osmotic pressure, O2 and CO2 tension), which 
may be controlled very precisely, and the physiological conditions, that may 
be kept relatively constant but cannot always be defined. Recent progress in 
the biology of cell adhesion is enabling cell culture models to better reproduce 
in vivo functions, allowing a better knowledge of the molecules involved in 
adhesion to extracellular matrix and neighbouring cells that are important 
regulators of cell behaviours138. One of the advantages of this technique is that 
although the number of cells obtained from small sample pieces of tissue is little, 
it can be increased in a short period of time139. The homogeneity of the sample 
is undertaken and in terms of pharmacological/toxicological investigation, less 
compound quantity is needed when compared to quantity required for animal 
model experiments. 
Another benefit of cell culture resides on the possibility of cryopreservation, 
which leads to reduce the risk of microbial contamination and morphological 
changes. Furthermore, work can be conducted using cells at a consistent 
passage number. 
Thus, the advantages of cell culture are fundamentally resumed in 4 topics: 
i) the cellular environment can be manipulated; ii) the cell type can be well 
defined; iii) the cells can be obtained in large quantities; and iv) many different 
cellular phenomena can be investigated.  These include growth, differentiation, 
locomotion, as well as the responses to hormones, drugs or carcinogens.  
 
The development of tissue and cell cultures owes, mainly, to the needs of 
medical research, such as the production of antiviral vaccines and the 
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understanding of neoplasia. An additional force of increasing pressure from 
public opinion has been the expression of concern by many animal-rights 
groups over the unnecessary of experimental animals. The introduction of more 
sensitive and more readily performed in vitro techniques, together with a very 
real prospect of assaying for inflammation in vitro, has promoted an 
extraordinary expansion of in vitro testing. In addition to cancer research and 
virology, other areas of investigation have become dependent on tissue culture 
techniques. The insight on the mechanism of action of antibodies, derived from 
monoclonal antibody techniques was, like the technique of cell fusion, a 
preamble of a new field of investigation based on genetic manipulation. Other 
areas of major interest comprise the study of cell interactions and intracellular 
control mechanisms in cell differentiation and development. Based on cell 
culture methodology, neurological research has greatly progressed on the last 
few years, contributing to disclose some of numerous mechanisms that role 
nervous function. 
Tissue culture technology has also been used for many routine medical or 
industrial applications. For instance, chromosomal analysis of cells derived from 
the amniotic fluid by amniocentesis can reveal genetic disorders in the unborn 
child140,141; viral infections can be tested qualitatively and quantitatively on 
monolayers of appropriate host cells142,143, and the toxicity of pharmaceutical 
compounds144,145, as well as, potential environmental pollutants may be 
measured in colony-forming and other in vitro assays146. Further developments 
in the application of tissue culture to medical problems may follow from the 
demonstration that cultures of epidermal cells form functionally differentiated 
sheets in culture147 and endothelial cells may form capillaries148, suggesting 
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possibilities in autografting and reconstructive surgery using individual’s own 
cells149,150,151. The prospects for implantation of normal cells from adult or fetal 
tissue-compatible donors or genetically reconstituted cells from the same 
patient, are now very actual149,150,148. The technical barriers are progressively 
being overcome. The practical feasibility of normal fetal neuron implantation 
into patients with Parkinson’s disease has been demonstrated152,153. There is 
newly evidence that cell culture allow autotransplantation of neuronal 
cells154,155.  
As it was mentioned previously, there are three varieties of cultured cells - 
primary cultured cells, cell strains and cell lines – all important tools to improve 
neurological discovery. Neuron isolation and the establishment of primary 
cultures offer several advantages for studies outside the complexity of the 
brain. First, enriched populations of neurons decrease the ambiguity of 
interpreting the cellular target of various test substances. Second, isolated 
neurons in culture allow direct access for application of pharmacological 
agents and electrophysiological recording. Third, cell culture allows precise 
control of the environment affecting the cell. These uniform conditions promote 
greater reproducibility in physiological measurements than whole animal 
studies. Fourth, cell culture allows continuous visual access for studies of 
morphological characteristics such as neuritogenesis, connectivity and 
toxicity156. The ability to maintain nerve and glial cells in primary cultures is 
essential for the advancement in the understanding of the developing nervous 
system. By using cell cultures, it has become possible to investigate cell-cell 
interactions that are difficult to study in vivo. However, the extent to which such 
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cell cultures actually mimic the processes in situ is uncertain and difficult to 
assess. Cells may behave differently in vitro because of factors such as 
differences in the enzymes used for cell dissociation, in culture medium, 
matrices used, and soluble factors added as well as changes in the 
environment and the absence of other cells normally present in the tissue from 
which the cells are derived. Mixed cultures are therefore preferable, because 
all the cells present in situ are also present in vitro157. 
Taking advantage of cardosins hydrolytic features, described in more detail in 
the last chapter, the present work aims the implementation of a new protocol 
for the establishment of primary neuronal cultures by using cardosins instead of 
trypsin. In this chapter it is described the isolation method, as well as, the 
different kind of assays, usually used to assess cell viability of cultured neurons.    
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3.2. Material & Methods 
 
 
3.2.1 Reagents 
 
Neurobasal medium, B27 supplement and trypsin (USP grade) were purchased 
from GIBCO. Mouse anti-MAP-2, rabbit-GFAP, glutamine, DNase (DN-25), 
hydrogen peroxide and trypan blue were purchased from Sigma Chemical Co. 
Goat anti-mouse IgG antibody conjugated to Alexa Fluor® 594 and goat anti-
rabbit IgG antibody conjugated to Alexa Fluor® 488 were purchased from 
Molecular Probes. All other reagents were from Sigma Chemical Co. or from 
Merck KGaA.  
 
 
3.2.2 Purification of cardosins 
 
Cardosins were purified according to Sarmento and colleagues158, by a 
method that allows the purification of high amounts of protein. 
Briefly, stigmas from fresh flowers were homogenised in a mortar and pestle in 
sodium citrate 100 mM, pH 3.5, and centrifuged. The supernatant was applied 
to a Hiload Superdex 75 semi prep (Amersham Pharmacia Biotech) equilibrated 
and eluted with 25 mM Tris–HCl pH 7.6 at a flow rate of 3 ml/min.  
The cardosins fraction obtained by size-exclusion chromatography is not further 
purified and, thus, compromise proteolytic activities from cardosins A0, A and B. 
Purity of cardosins was assessed by SDS–polyacrylamide gel electrophoresis 
(SDS–PAGE) according to Laemmli159 after staining with Coomassie Brilliant Blue. 
Cardosins fractions were quantified and concentrated by lyophilization. Dried 
protein was stored at −80 ◦C (appendix: protocol 1, for details).  
Periodically, cardosins activity was checked by an established method based 
on the hydrolysis of the synthetic peptide Lys-Pro-Ala-Glu-Phe-Phe(NO2)-Ala-Leu  
(appendix: protocol 2). 
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3.2.3 Cell isolation and culture  
 
Primary cultures of brain cortical cells were prepared from Wistar rat embryos 
(E15-E16), as described by Agostinho and co-workers160 with minor 
modifications (Fig. 3.1).  
Animals were handled following the approved guidelines of national ethical 
requirements for animal research and with the European Convention for the 
Protection of Vertebrate Animals Used for Experimental and Other Scientific 
Purposes. Briefly, pregnant females were sacrificed by cervical dislocation, the 
uterus removed under sterile conditions and the embryos dissected on a 
100mm Petri dish with cold Ca2+- and Mg2+-free Hank's Balanced Salt Solution 
(CMF-HBSS), pH 7.4. The cortecis were carefully removed and placed in 
CMF-HBSS containing 0.3% of BSA in a 35mm Petri dish for subsequent removal 
of the meninges. After slightly minced, the cortecis were digested with 0.1% 
trypsin or 0.1% cardosins in CMF-HBSS containing 0.008% DNAse I, for 10 minutes 
at 37°C. Cardosins concentration was optimised in order to accomplish 
equivalent cell viability for both types of culture.  The digestion was stopped by 
adding 10% fetal calf serum (FCS) and washing. 
 
 
 
Figure 3.1 – Primary culture establishment:  (a) sacrificed pregnant rat, (b) removal of the 
embryos (E15-16) from the uterus, (c) cortex dissection and (d) removal of the meninges.  (These 
photographs were kindly provided by N. Rosa). 
 
 
The digested tissue was mechanically dissociated by gentle forcing through a 5 
ml glass pipette. After centrifugation (140 x g, 5 minutes), the cells were 
resuspended in Neurobasal Medium supplemented with 2% B27, 0.5mM 
L-glutamine, 100U/ml penicillin and 100µg/ml streptomycin. Cell viability was 
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assessed by Tripan blue exclusion and counting on a hemocytometer. The cells 
were plated on poly-D-lysine (0.1 mg/ml) coated multi-well plates, at a density 
of 0.5x106 cells/cm2, or 10 mm glass coverslips at a density of 0.25x106 cells/cm2. 
The cells were maintained at 37°C in a humidified 5% CO2/95% air atmosphere. 
 
 
3.2.4 MTT assay of cell viability 
 
The viability of cultured cells was quantitatively assessed by the MTT (3-(4,5-
dimethylthiazal-2-yl)-2,5-diphenyl-tetrazolium bromide) reduction test. Living 
cells convert MTT to a dark blue, water-insoluble formazan product formed by 
the reduction of the tetrazolium ring of MTT by the mitochondrial succinate 
dehydrogenase161.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 – (a) Conversion of MTT tetrazolium in its formazan 
product. The reaction is conduced by dehydrogenase 
enzymes in metabolically active cells. (b) Schematic 
representation of MTT reduction and consequent formation 
of purple precipitate (formazan product). Unviable (white) 
and viable (purple) cells correspond to the small spheres 
into each well (bigger spheres) of a multi-well plate. Cell 
viability is assessed by measure of optical density.    
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As it is represented in Fig. 3.2, colour intensity is directly proportional to cell 
dehydrogenase activity and consequently indicates de ratio of viable cell in 
the cultures.  The cultures were incubated with 300µl of MTT solution (0.5mg/ml 
in Krebs buffer) at 37°C for 2 hours. After washing, the cultures were incubated 
with 0.08N HCl in isopropanol to dissolve the blue formazan product, and the 
optical density read at 570nm in a microplate reader with background 
subtraction at 620nm. Results were expressed as percentage of the optical 
density in controls. 
 
3.2.5 Cell Survival Assays 
 
Glutamate excitotoxicity: The optimum glutamate concentration for starting 
cultures of embryonic neurons is 25 µM (Brewer et al., 1993162). This relatively high 
glutamate concentration may be a useful mimic of the leaky blood brain 
barrier of embryos. Therefore, survival of neurons isolated with cardosins versus 
trypsin was evaluated with and without glutamate in the culture medium. Cell 
survival was determined 24 hours after by using the MTT assay. 
 
Cell response to H2O2: 7 days old cultures were treated without or with H2O2 
(10 and 50 µm). Cell survival was determined 24 hours after by using the MTT 
assay. 
 
 
3.2.6 Immunocytochemistry 
 
Cell identity and morphology were evaluated after the immunocytochemical 
labeling of the cortical neurons with an anti-MAP-2 (microtubule-associated 
protein 2) antibody, and for the astrocytes with an anti-GFAP (glial fibrillary 
acidic protein) antibody. After removal of the culture medium and washing 
with phosphate buffered saline (PBS), the cells were fixed with 4% 
paraformaldehyde in PBS for 10 min, followed by permeabilization with 0.2% 
Triton X-100 in PBS for 10 min. After blocking for 90 min with 0.2% gelatin in PBS, 
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the cells were incubated with the anti-MAP-2 (1:500) and anti-GFAP (1:200) 
antibodies for 90 min. After extensive washes in PBS, the cells were incubated 
for 60 min with the secondary antibodies: anti-mouse IgG conjugated to Alexa 
Fluor 594 (2 µg/ml) and anti-rabbit IgG conjugated to Alexa Fluor 498 (1 µg/ml). 
To assess the specificity of the immunostaining, the primary antibodies were 
omitted in some coverslips. Finally, the coverslips were washed thoroughly and 
mounted on glass slides in fluorescent mounting medium (DAKO). The detailed 
experimental proceeding is available in the appendix section, as protocol 3. 
The preparations were observed in a Carl Zeiss fluorescence microscope, and 
images were acquired with the AxioVision software (Carl Zeiss Imaging Systems).  
 
3.2.7 Immunocytochemical and morphometric analysis of cell cultures 
 
In order to obtain data about neurite outgrowth and neuronal sprouting after 
brain disaggregation using cardosins, the number of neurites and their length 
were evaluated in four randomised areas of each experiment, in three 
independent preparations. All analyses were developed for cultures established 
with trypsin for further comparison. The results were acquired by using the 
AxioVision software, followed by statistical evaluation with Student’s t-test.  
 
3.2.8 Data analysis 
 
Data are expressed as means ± SEM. Statistical significance was determined by 
using Student’s t-tests, *p≤0.05, **p≤0.001 and ***p≤0.001, for significant, very 
significant and extremely significant, respectively, as indicated in the figure 
legends. 
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3.3. Results & Discussion 
 
3.3.1 Cell yield and viability 
 
To study the feasibility of using cardosins to prepare neuronal cell cultures, its 
ability to dissociate cortical tissue from rat embryonic brain was determined, 
and it was compared the cell yield and the cell viability with those of an 
established protocol to prepare cortical cultures using trypsin160. The cell yield of 
cortex dissociation with increasing concentrations of cardosins mixture was 
previous determined163,164. The optimal concentration of cardosins for the 
isolation of cortical cells was 1mg/ml since the cell yield at this concentration 
was similar to that obtained with trypsin; the use of higher concentrations of 
cardosins did not further increase the cell yield.  Cortex dissociation with 
1 mg/ml cardosins yielded a number of cells, approximately 20x106 cells/mg 
wet tissue, similar to the yield obtained with trypsin at the concentration 
routinely used in the laboratory to isolate cortical cells from rat embryos. 
Immediately after cell isolation, cell viability was assessed by trypan blue 
exclusion method (Fig. 3.3).  
 
Figure 3.3 – Cell viability of isolated neurons assessed by Tripan blue method. 
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The percentage of viable cells isolated with cardosins (86.49 % ± 0.81 of total) 
was quite similar to the viability of cells dissociated with trypsin (85.56 % ± 3.30). 
Significantly, the viability of cells obtained with cardosins was less variable than 
those obtained with trypsin.  
 
Cell viability was also examined upon culturing the cells (Fig. 3.4). Using the MTT 
reduction assay, it was possible to achieve similar viabilities for cells isolated with 
cardosins or with trypsin 3 hours after plating, but at 24 h the viability of cells that 
have been isolated with cardosins was much higher than the viability of cells 
isolated with trypsin (p≤0.001). The difference in viability was no longer 
significant upon 7 days in culture. The increase in cell viability observed upon 
culturing is due to cell recovery after the isolation and to the death and 
detachment of nonviable cells, leading to the increase in the percentage of 
cells capable of reducing MTT. The faster increase in cell viability observed for 
the cells isolated with cardosins as compared to cells isolated with trypsin 
suggests that cardosins are less harmful to neuronal cells. 
 
Figure 3.4 – Cell viability of cultured neurons for 7 days measured by MTT reduction assay.  
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3.3.2. Immunocytochemical and morphometric analysis of cell cultures 
  
In order to identify the cells present in the cultures and to follow their 
development the cultures were immunolabeled for a neuron specific protein, 
the microtubule-associated protein-2 (MAP-2), and for a glial cell marker, the 
glial fibrilary acidic protein (GFAP). The immunofluorescence images shown in 
Fig. 3.5 evidenced that neurons isolated with cardosins and subsequently 
cultured exhibited a normal morphology, with neurites extending from the cell 
bodies, demonstrating a normal cellular growth, as a result of re-expression of 
neuritogenesis, apparently without damage. Actually, longer neurites were 
observed in cultures prepared with cardosins, 24 hours after plating, as 
compared to the cultures of cells dissociated with trypsin (Fig. 3.5 a,b) but the 
differences were no longer apparent in cells cultured for longer periods (Fig. 3.5 
c,d). Immunostaining for GFAP showed the presence of astrocytes in both 
cultures (Fig. 3.5 e,f), which is not unexpected since the Neurobasal medium 
with the B27 supplement does not hinder the proliferation of nonneuronal cells. 
Since the growth of astrocytes appear to be similar in both cell cultures, the 
differences in the neuronal development cannot be accounted for by 
differences in astrocyte support.  
 
 
Quantitative analysis showed that neurons isolated with cardosins exhibited 
larger numbers and longer neurites (Fig. 3.6). The number of neurites extending 
longer than 25 µm was 68.0 ± 5.0 in cells that had been isolated using cardosins, 
which is significantly larger than in trypsin isolated cells (39.5.0 ± 4.0, p≤0.01). 
Their maximal length was 35.0 µm ± 4.0 for trypsin generated cultures, and 50 
µm ± 6.0 (p≤0.01) for cultures obtained with cardosins. No differences were 
perceptible after 7 days in culture. These morphological data are in agreement 
with cell viability data shown in Fig. 3.5.  
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Figure 3.5- Immunocytochemical characterization of cell cultures prepared by cardosins or 
trypsin dissociation of embryonic brain cortex. The cells were cultured for 1 day (a, b), or for 7 
days (c-f) before fixation and immunolabeling for MAP-2 (a-d), a neuronal marker, and for GFAP 
(e, f), a glial marker. Fluorescence microphotographies c and e, and d and f are from the same 
fields. (Scale bar = 50µm.) 
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Figure 3.6 - Morphometric analysis of neurons cultured for 1 or 7 days after cell isolation 
with cardosins (C) or trypsin (T). The cultures were immunostained for MAP-2, and the 
neurite length and the number of neurites extending longer then 25 µm were 
determined in 4 randomly chosen fields. Data shown are the means ± SEM of 
determinations in 3 independent preparations. 
 
Synapse is the means by which an impulse is transmitted between neural 
cells165. The axon of one neuron synapses with the dendrites of other neurons. 
The many-branched, terminal portion of an axon not only may synapse with 
many other neurons but also may synapse with numerous points on a single 
neuron. Each terminal branch of an axon ends in a synaptic bouton. A gap 
called the synaptic cleft separates the presynaptic membrane of a synaptic 
bouton from the postsynaptic membrane of a dendrite, or a non-nervous target 
cell, such as a muscle cell. Transmission across a cleft is accomplished by the 
diffusion of a chemical transmitter released by synaptic vesicles in the bouton 
of the axon. Impulses travelling down the length of the axon of the presynaptic 
neuron change the permeability of the bouton membrane allowing Ca2+ ions 
to diffuse into the bouton from the surrounding fluid. The presence of Ca2+ 
causes the synaptic vesicles to fuse with the presynaptic membrane and 
rupture releasing the transmitter chemical into the cleft. The transmitter 
chemical, such as acetylcholine, binds weakly with the postsynaptic 
membrane. This action alters the potential of the membrane and gives rise to a 
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new impulse in the postsynaptic neuron166. Immunocytochemistry allows, not 
only assessing to the cell morphology but, in the some cases, may reveal cell 
functionality.  Thus, new synaptic boutons formation reveals the state of 
synapse development and plasticity.  
An apparent rearrangement of microtubule loop architecture occurs during 
bouton division. The control of microtubule organization by MAPs may represent 
a common mechanism for regulated growth cone motility as well as synaptic 
growth and plasticity167. In this sense, immunocytochemistry was used to 
calculate the number of synaptic boutons.  
The graph represented in the Fig. 3.7 is the result of statistical treatment of data 
obtained by counting the referred fluorescent points (correspondent to the 
synaptic boutons) in MAP-2 immunolabelled preparations of cortical neurons. 
The results – 182 ± 15 and 180 ± 18 for cardosins and trypsin, respectively - 
indicated that both neuronal cultures, 7 days after brain disaggregation, have 
the same synaptic plasticity evidencing normal growth-cone motility. This is 
further confirmed by the equivalent pathfinding shown by the developed 
neurons isolated with cardosins or with trypsin. Fig 3.8 shows representative 
images of cultures established by cardosins and trypsin after 7 days, where it is 
possible to visualise the synatic boutons through the neurite network.  
 
Figure 3.7 – Comparison of the number of synaptic boutons for the two types of cultures, after 7 
days incubation period (determined in 4 randomly chosen fields). Data shown are the means ± 
SEM of determinations in 3 independent preparations. 
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Figure 3.8 – Synaptic boutons. Representative photographs of cortical neurons obtained by using 
cardosins or trypsin in the isolation procedure (as described in the material & methods of this 
chapter).
cardosins 
trypsin 
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3.3.3 Functional analysis of cell cultures 
 
 
A preliminary study, based on neurotransmitter release in response to 
membrane depolarization, was performed by Rosa, 2002163 and neuronal 
functionality after using cardosins for brain disaggregation was verified.  The 
neurotransmitter GABA was chosen because of its abundance in the cortex 
and because its release from cultured cells is well characterized168. GABA 
release in the absence of stimulation was quite high, about 15% of the cell 
content, but similar in cardosins- and trypsin-prepared cultures. This elevated 
release of neurotransmitters in the absence of stimulation is often observed in 
embryonic cultures due to high levels of spontaneous activity169. Upon 
depolarization induced by increasing K+ concentration in the extracellular 
medium, an additional release of GABA was observed, about 5% of the cell 
content, showing that the cells were capable of responding to a depolarizing 
stimulus, as expected from cells keeping a membrane potential. 
To determine whether the cell cultures prepared with cardosins exhibit 
physiological responses several tests were developed.  
A number of studies have indicated that glutamate can play an important role 
in developmental plasticity. The speed and direction of growth of cultured 
neurites is influenced by the application of glutamate170. 
A significant part of this modulation of neuritic outgrowth may depend on 
glutamate receptor mediated changes in intracellular Ca2+. 
Synaptogenesis and axonal branching are also influenced by glutamate 
receptors, as studied in retina ganglion cells, cerebellum, somatosensory cortex 
and superior colliculus. Migration of neurons during early development is 
regulated by glutamate, as shown in cerebellar granule cells. Glutamate, to a 
large degree acting through Ca2+, also plays a critical role in modulating gene 
expression. However, high levels of extracellular glutamate inhibit the import of 
cystine, resulting in the depletion of glutathione and a form of cell injury called 
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oxidative glutamate toxicity. For this reason, glutamate is extensively used in 
excitotoxicity studies. 
The physiological consequences of extracellular glutamate are mediated by 
three classes of membrane proteins within the CNS. These are ionotropic 
glutamate (iGlu) receptors, metabotropic glutamate (mGlu) receptors 
(receptor superfamily that includes GABA receptor), and the cystine/glutamate 
antiporter. They are responsible for the majority of excitatory neurotransmission 
and also for a great deal of CNS pathology. 
In cases of stroke or trauma, excessive extracellular glutamate leads to nerve 
cell death via the activation of NMDA receptors. This phenomenon, which can 
be reproduced in cell culture, is termed excitotoxicity171. 
 
Little is known on the expression and function of individual glutamate receptors 
during the prenatal development of the CNS. Recently, Di Giorgi Gerevini & 
colleagues172 described the temporal profile of mGlu receptor expression in 
different brain regions from embryonic day 12 (E12) to the adulthood in relation 
to the sites of active neurogenesis. After glutamate receptors are expressed, 
neurons are susceptible to excitotoxicity from excess glutamate173. 
 
Based on these observations excitoxicity studies were carried out to assess 
neuronal physiology. Therefore, after 7 days of cultures establishment, survival of 
neurons isolated with cardosins versus trypsin was compared in culture medium 
with and without glutamate (Fig. 3.9). For neurons isolated with cardosins or 
trypsin, survival without glutamate was 34 or 52% better than with 25 µM 
glutamate, respectively (P<0.05). 
 
 Cultured cells were also examined to an additional toxic challenge (Fig. 3.10). 
Thus, after 7 days in culture, the cells were treated with H2O2, a reactive oxygen 
species known to increase oxidative stress and to cause neuronal death174. 
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Figure 3.9 - Glutamate excitotoxicity.  Cell cultures (7 days-old) were exposed to glutamate 
(25 µM) and cell viability was assessed, after a 24 h incubation period, with the MTT test. The 
results are presented as percentage of controls for trypsin and are expressed as means ± SEM of 
at least four independent experiments. *p≤0.05, as compared to cells isolated with trypsin. 
 
 
Oxidative stress is believed to be implicated in a wide variety of human 
degenerative disorders of the CNS, including Alzeimer’s disease, Parkinson´s 
disease and in pathological conditions such as ischemia174,175176. Rat embryonic 
neurons are particularly sensitive to H2O2 and the exposure of neuronal cultures 
to H2O2 induces a concentration-dependent (10-1000 µM) cell death by 
estimative after 24 hours177.  
 
As shown in Fig. 3.10, H2O2 caused a decrease in MTT reduction in both cultures, 
showing that neurons were responding in the same manner to the toxic insult. 
However, neurons obtained with cardosins showed higher cell viability both in 
control and in cultures treated with 10 µM H2O2 (p≤0.05), that could be a result 
of cellular integrity and consequent better coordination of all oxidative stress 
mechanisms. 
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Figure 3.10 - Cell response to a toxic challenge - H2O2 effect.  Cell cultures (7 days-old) were 
exposed to H2O2 (10 or 50 µM) and cell viability was assessed, after a 24 h incubation period, with 
the MTT test. The results are presented as percentage of controls for trypsin and are expressed as 
means ± SEM of at least four independent experiments. *p≤0.05, as compared to cells isolated 
with trypsin. 
 
 
 
1 2 3
0
25
50
75
100
125
150
10 µM 50 µM [H2O2]
*
*
0 µM
Trypsin
Cardosins
M
TT
 r
e
d
u
c
ti
o
n
 (
%
)
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4. MMPs in the mechanisms of neuronal regeneration and recovery 
4. MMPs involvement in the mechanisms of neuronal 
regeneration and functional recovery 
 
4.1 Brief introduction 
 
In addition to their structural function, extracellular matrix (ECM) molecules play 
an important role in the structural rearrangements that accompany many 
physiologic, as well as pathologic, processes. To preserve tissue integrity during 
these processes, ECM synthesis and degradation must be exquisitely regulated. 
Cell-cell and cell-matrix interactions play critical roles in all phases of 
developmental tissue remodelling, where MMPs function in the degradation of 
a broad-spectrum of ECM and basement membrane proteins, including 
collagens, laminin, fibronectin, glycoproteins and proteoglycans. 
 
Investigation on the MMPs’ target molecules can help ascertain and explain 
MMPs’ roles in brain physiology. Numerous substrates of potential physiological 
significance have been proposed as target molecules for theses matrix 
proteases. For example, in vitro, these enzymes cleave proteoglycans, including 
chondroitin sulfate proteoglycan (CSPG), that are abundant in the adult 
nervous system and evoke a strong avoidance reaction by a variety of 
neuronal subtypes.  
Furthermore, MMPs have been considered as candidate molecules for 
enabling remyelination, because they can degrade all protein components of 
the ECM as demonstrated by McCawley and Matrisian, 2001178. 
Although MMPs are known to have detrimental roles after injury179,180, their 
consistent upregulation in the damaged CNS invites the hypothesis that these 
proteases have important functions in the repair process, particularly in 
remyelination. 
Preceding studies have shown that an increase in MMP-9 levels occurs during 
the period of developmental myelination in both the corpus callosum and the 
                                                          
178 McCawley LJ, Matrisian LM (2001) Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin 
Cell Biol 13: 534-540. 
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optic nerve181,182: the in vitro inhibition of MMP-9 reduced oligodendrocytes 
process extension.  In addition, Larsen and co-workers in 2003183 showed that 
mice lacking MMP-9 are impaired in myelin reformation after lysolecithin-
induced demyelination. This deficiency may be explained at least in part by the 
failure to clear the accumulation of NG2 (a cell membrane-associated 
chondroitin sulphate proteoglycan present in nervous tissue cells that have not 
yet specialized into oligodendrocytes) an inhibitory proteoglycan that retards 
the maturation and differentiation of oligodendrocytes essential for 
remyelination. These results showed for the first time that some of the MMPs that 
are expressed after CNS injury have reparative functions, suggesting that the 
selective enhancement of these MMP activities may improve recovery from 
CNS insults. 
 
As mentioned earlier, laminins, which are heterotrimers of α, β and γ chains, are 
target molecules of MMPs activity, representing one of the major components 
of all basal lamina in vertebrates and invertebrates. These glicoproteins play 
key roles in cellular mechanisms involving several signal paths. Mutations in 
laminin genes in humans and mice have demonstrated critical roles for laminins 
in diverse tissues, including muscle, kidney, lung, skin, and placenta184. Laminins 
possess considerable neuritepromoting activity with respect to primary cultured 
neurons taken from the mammalian embryonic brain. A role for laminin 
interacting with oligodendrocyte laminin-binding integrins in the formation of 
myelin membrane has been reported185. Purified laminins and laminin fragments 
affect cultured central neurons in numerous ways, including promotion of 
adhesion, migration, survival, and neurite outgrowth186. It has been stated that 
laminins are present in high amounts during periods of axonal growth and their 
expression levels diminish later in development190,186. Laminin immunoreactivity 
increases at locations of seizure-induced axonal sprouting, while facilitation of 
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laminin degradation in the hippocampus leads to accelerated neuronal cell 
death187. Laminins are also critical for formation and function of the peripheral 
nervous system, including migration of sympathetic and sensory neuroblasts, 
myelination of peripheral axons, and maturation of the skeletal neuromuscular 
junction188. Concerning this issue and using cultured dorsal root ganglionic 
(DRG) neurons, Zuo and co-workers (1998)189 described that neuritic outgrowth 
was increased significantly by first treating the nerve sections with MMP-2, which 
repressed the inhibitory activity of CSPGs and unmasked the neurite-promoting 
activity of associated laminin. Parallel results were obtained for MT5-MMP 
(MMP-24)190. 
 
Finally, regarding MMPs’ activity on growth factores, it is well established that 
neurotrophins such as nerve growth factor (NGF) and brain-derived 
neurotrophic factor (BDNF) participate in neuronal survival and synaptic 
plasticity. It was recently reported that their precursors contain consensus sites 
for cleavage by MMP-3 and MMP-7191. Indeed, the proteases can 
extracellularly cleave secreted pro-neurotrophins192. 
Given the above findings it is reasonable to believe that imbalance between 
the normal levels of MMP activity promotes remodeling, and inhibition of their 
actions by TIMPs may result in abnormal development and consequently to a 
pathological state. 
 
Hence, MMPs are crucial molecules for axonal guidance development and, 
therefore may facilitate cell migration to injured areas that require 
replenishment or may promote process extension as a prelude of cell 
interaction. 
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Other beneficial aspects could include a role in angiogenesis, in the release of 
growth factors sequestered by the ECM or in the subtle processing of cell-cell 
recognition molecules that allow repair (for review, see Yong and colleagues, 
2001180). 
In the future, all these approaches and further investigation will lead to the 
emergence of an integrated view on proteases in neurobiology and will 
provide a theoretical basis for modulating proteolytic activities, mainly, to 
achieve therapeutic goals in neurodegenerative diseases. 
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4.2 Material & Methods 
 
4.2.1 Immunocitochemistry  
 
Cell identity and morphology were evaluated after the immunocytochemical 
labelling of the cortical neurons with an anti-MAP-2 antibody, and for the 
astrocytes with an anti-GFAP, as described in detail in the preceding chapter in 
section “3.2 Material & Methods” (appendix: Protocol III). For additional cellular 
localization of MMP-2, neuronal cultures were incubated at a dilution of 1/200 
of rabbit polyclonal anti-MMP-2 antibody (H-76, Santa Cruz Biotechnology). 
 
4.2.2 MMPs Activities 
 
Conditioned media of cell cultures were collected 24 hours, 4 and 7 days after 
culture establishment and analyzed by gelatin zymography193 (appendix: 
Protocol IV). 
Briefly, media samples containing 100µg of proteins were mixed with 2x SDS 
sample buffer [0.25M Tris (pH 6.8), 5% (w/v) SDS, 20% glycerol] and 
electrophoresed directly without boiling, under nonreducing conditions, on 10% 
polyacrylamide gels containing 0.1% gelatin. 
The electrophoresed proteins were renatured at room temperature for 30 
minutes in a 2.5% v/v Triton X-100 solution, before incubating at room 
temperature for 30 minutes in developing buffer [50mM Tris (pH 7.6), 0.02M 
NaCl, 5mM CaCl2]. 
Gels were incubated in fresh developing buffer overnight at 37°C. The gels 
were stained (1% Coomassie Blue R-250, Sigma), distained in 25% methanol, 10% 
acetic acid and MMPs activity demonstrated by the presence of clear bands 
upon a blue background.  
Quantification of gelatinolytic activities, active MMP-2 and transcripts 
expression was performed on at least four independent experiments. 
                                                          
193 Liota, L.A. and W.G. Stetler-Stevenson (1990) Cancer Biology, 1, 96-106 
4. MMPs in the mechanisms of neuronal regeneration and recovery 
4.2.3 RNA preparation and RT-PCR 
 
A. Isolation System 
 
Total RNA from cultures (different times and conditions of incubation) was 
isolated using the Trizol Reagent (Life Technologies, Cat. No.15596) according 
to the manufacturer's instructions by a simultaneously disrupt cells and 
inactivate ribonucleases method, as described in protocol V (appendix). 
Each RNA sample was extracted from 3 to 5 neuronal cultures of the same 
isolation procedure. To inactivate RNases, all solutions used were prepared with 
DEPC-treated water [0.1% (v/v) and incubation for 16 hours followed by 
autoclaving at 120ºC, 1atm, 60 minutes] and reagents were nuclease-free. 
Glass labware was heat-treated at 200ºC for 16 hours and plasticwear was 
carefully washed with chloroform194. 
Briefly, cell lysates were homogenised in Trizol reagent and the mixture was 
separated in 3 phases by addition of chloroform. The aqueous phase, 
containing the RNA was transfer to a fresh tube and precipitated with isopropyl 
alcohol. The RNA pellet was dried and dissolved in 20µl of nuclease-free water. 
RNA samples were kept at -20ºC for short-term storage and at -80ºC for long-
term storage.  
 
 
B. Analysis of RNA 
 
The concentration and purity of the RNA samples were determined by 
spectrophotometry. The optical density of convenient dilution of samples was 
measured at 260 nm and 280 nm. The A260/A280 ratio was calculated for every 
sample and compared to reference values of 2.0±0.15195. Samples which the 
A260/A280 ratio laid between the higher and lower values were considered 
free of contaminants such as proteins, phenol and salts. 
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For samples that accomplished the purity criterion, the concentration was 
calculated with the formula: [RNA]µg/ml = A260 x dilution x 40.0195.  
Integrity of RNA was determined by agarose gel electrophoresis, after a careful 
wash of the electrophoresis apparatus with RNase free-water.  The amount of 
RNA loaded per lane was 0.5 to 10 µg and electrophoresis were run at 5 V/cm 
until bromophenol blue has migrated two-thirds of the gel. Finally, gels were 
visualised and scanned under UV radiation. 
 
C. Relative quantitative reverse transcriptase polymerase chain reaction 
(RT-PCR) 
 
Expression studies of MMPs and TIMPs were done by determination of the 
relative amounts of mRNAs in total RNA extracts by relative quantitative RT-PCR. 
First strand cDNA was synthesized using the 1st Strand cDNA Synthesis Kit for RT-
PCR-AMV (Roche) or TaqMan Reverse Transcription Reagents (Applied 
Biosystems) from 1mg of total RNA that has been confirmed to be pure and 
non-degraded. The reverse transcription (RT) reaction conditions were 25ºC for 
10 minutes, 48°C for 35 minutes, 95°C for 5 minutes. Specific primer pairs were 
designed based on sequences deposited in databases having in mind co-
amplification with β-actin fragment. Primer sequences are listed in Table 4.1. To 
test for differences in total RNA concentration among samples, mRNA level for 
rat β-actin were also determined by RT-PCR. 
Thus,  multiplex PCR reactions were performed in 1.25µl of cDNA as template, 
with 3mM MgCl2, 0.2mM dNTP mix, 0.4 µM of each primer (and 36pM for 
β-actin). 
PCR program for conditions were MMP-2, TIMP-1 and TIMP-2 was as follows:  
 
i) Denaturation: 94ºC, 30 seconds; 
ii) Annealing: 55ºC, 30 seconds; 
iii) Extension: 72ºC, 1 minutes; 
iv) Cycle number: 29 cycles; 
v) Last extension step: 72ºC, 10 minutes. 
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For MMP-9, the program was similar except for annealing temperature of 57ºC 
and the number of cycles of 34. 
 
 
Table 4.1 – Specific primer pairs sequences  
Gene  Primer sequences 
MMP-2  5'-GATTGACGCTGTGTATGAGG-3' 
5'-AGTCTGCGATGAGCTTAGG-3'    
MMP-9  5'-TGTACCGCTATGGTTACAC-3'    
5'-TCCGCGACACCAAACTGG-3'    
TIMP-1  5'-CCACCTTATACCAGCGTTATG-3'    
5'-GAACAGGGAAACACTGTGCA-3'    
TIMP-2  5'-GCAGATAAAGATGTTCAAAGG-3'   
 5'-CAGTCCATCCAGAGGCAC-3'    
β-actin  5'-GACTACCTCATGAAGATCCT-3'  
5'-ATCTTGATCTTCATGGTGCTG-3'   
 
 
 
PCR products were separated by 1.5-2% agarose gel electrophoresis (5 V/cm), 
stained with ethidium bromide and scanned under UV radiation. Densitometric 
analysis was performed using NIH Image 1.60 software196. For each sample, the 
ratio between the fluorescence of the target gene and the internal standard 
was used to overcome variability between samples such as RNA quality, RNA 
quantification errors, and random tube-to-tube variation in PCR and reverse 
transcription reactions. Results are mean values of, at least, three independent 
experiments. Images from representative experiments are shown. 
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4.2.4 Western blot analysis 
 
Western blots were performed on cell extracts fallowing the procedures as 
described in Protocol VI and Protocol VII (appendix). 
Cells were collected from three different cultures in each condition and 
analyzed in triplicates. Each culture dish was rinsed three times with Krebs 
solution or PBS at 4ºC. The cells were collected by scraping into an extraction 
buffer containing 25 mM Tris-HCl, 2.5mM EDTA, 2.5mM EGTA, 1% Triton X-100, 
supplemented with 1mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride 
(PMSF), 55µM leupeptin, pH 7.4 at 4ºC. 
Protein concentration was determined using a BCA Protein assay kit (Pierce) 
and 35 µg of extract were boiled for 5 min after adding 2x concentrated 
sample buffer (100mM Tris-Bicine, 2% β-mercaptoethanol, 2% sodium dodecyl 
sulphate, SDS). Equals amounts of protein were separate by electrophoresis 
(appendix, Protocol VI) on a 7.5% SDS-polyacrylamide gels (SDS-PAGE) and 
transferred to nitrocellulose membranes (appendix, Protocol VII). 
These were then blocked for 1 hour at room temperature in 5% skim-milk (w/v) 
in Tris-buffered saline (137mM NaCl, 20mM Tris-HCl, pH 7.6) containing 0.1% 
Tween 20 (TBS-T) before immunoblotting. 
Blocked membranes were incubated in TBS-T overnight at 4ºC with primary 
antibodies (rabbit polyclonal anti-laminin 1/500, rabbit polyclonal anti-MMP-2 
(H-76) 1/200, mouse monoclonal anti-MMP-9 1/500 and rabbit polyclonal 
anti-β-actin (H-300) 1/500). Rabbit polyclonal antibody against β-actin was used 
as a loading control for Western blotting. 
After three washes with TBS-T, the membranes were incubated for 2 hours at 
ambient temperature with the HRP labelled second antibody, diluted 1:1000 in 
TBS-T. 
The membranes were then washed three times with TBS-T and detection was 
carried out with ECL reagents (Amersham Pharmacia Biotech) following the 
manufactures instructions. 
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4.2.5 Mechanical lesions and primary cultures treatments 
 
Embryonic rat neurons were precultured for 7 days to allow neurons to 
elaborate neuritis. Neuronal lesions were performed following the model of 
stylet transaction, described by Morrison and co-workers197. Subsequently, all 
culture treatments were carried out198, by adding pan-laminin antibody (1:200) 
and RGD peptide (50 µM) to the culture medium. 
The effects of RGD-peptide and anti-laminin antibody on neurite outgrowth 
were determined, 24 hours post-lesion, both by analysing the number of 
neurons with neurites close to the scratched vicinity and by measuring the 
neurite length of randomly selected neurons. Neurites of growing neurons were 
visualized after immunolabelling as described under immunocytochemistry. 
Gelatinase activity and MMPs and TIMPs mRNA expression were also 
investigated. 
 
 
4.2.6 Data analysis 
 
Gelatinolytic activities on zymograms, mRNA expression and western blot 
analysis were expressed as a percentage of the controls ± SEM. Student's t-tests 
were used for statistical analysis. 
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4.3. Results & Discussion 
 
Although the role of MMPs and TIMPs in the morphogenesis of non-neural tissues 
has been investigated, to date few studies have analyzed their expression 
during CNS development. Even though, as mention above these extracellular 
molecules are closely related with neuritogenesis and sprouting191,192,199. Before 
analysing their expression/activity patterns, some morphological studies were 
carried out, fallowing the procedures described in the section of 
Immunocytochemistry of Material & Methods of chapter 3. The 
immunofluorescence images shown in Fig. 4.1 reveal that neurons isolated with 
cardosins (or with trypsin) and cultured exhibited a normal morphology, with 
neurites extending from the cell bodies, evidencing a normal cellular growth, as 
a result of re-expression of neuritogenesis, apparently without damage. 
Furthermore, double labelling studies have clearly revealed MMP-2 expression 
by neurons in both types of culture.  
 
 
 
4.3.1 Expression and activity of ECM proteins 
 
Since growth development, in particular neuritogenesis, are closely related with 
proteolytic activity of ECM, expression/activity experiments were performed. 
MMPs are expressed and secreted as inactive precursors that are activated by 
the removal of an N-terminal propeptide200,201,202. The latent and active forms of 
each enzyme can be differentiated on the basis of their molecular weights 
(MW) using zymography198,202.  
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Figure 4.1 – Double immunofluorescence labelling of embryonic cortical neurons isolated with 
cardosins (A) or by trypsin (B). Cultured neurons for 7 days were double stained for MAP-2 (neuron 
marker - red) and for MMP-2 (gelatinase A - green) and consequently detected with Alexa 594-
conjugated secondary anti-mouse antibody and with Alexa 488-conjugated secondary anti-
rabbit antibody. 
A 
B 
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On gelatin zymography, the detect gelatinolytic activity present in culture 
medium corresponds to the active form of MMP-2. Results for pro-MMP-2 
activity were not perceptible.  
Fig 4.2 shows a zymography gel where it can be clearly notice, for the first day 
in culture, a great gelatinolytic activity of cultured neurons isolated with 
cardosins. In contrast, it can be visualised a weak band resulted from a smaller 
amount of active gelatinases present on conditioned medium of cultures 
ascertain with trypsin.    
 
 
Figure 4.2 – Gelatin zymographic analysis in the conditioned media of primary neuronal cultures. 
A - Representative gelatin zymography of cultures ascertain by using cardosins versus trypsin 
(100 µg of conditioned media were analysed for the two different types of cultures at 1, 4 and 7 
days after culture establishment). The proteolytic bands correspond to active-MMP-2 and the 
experiments show a great activity for cultures established with cardosins, in contrast to cultures 
generated with trypsin. B - statistical analysis of the MMP-2 densitometric data presented as a 
percent of maximal activity. The results (mean ± SD) shown are from 5 independent tissue 
samples. Statistically significant differences from controls are designated by ***, P<0.01.  
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On these gels, it was not detected gelatinolytic activity corresponding to the 
92-kDa type IV collagenase, MMP-9, or also called, gelatinase B. 
In fact, MMP-9 expression during physiological development is very low when 
compared to other molecules under study, but MMP-9 transcriptional 
overexpression is strongly induced in brain pathological states203.  
Besides regulation by zymogene activation, most MMPs are regulated at 
transcriptional level and their activity is also regulated by specific inhibition 
(TIMPs). As it has been described beforehand, several evidences indicate that 
the expression of MMP-9 is very low in non-pathological conditions. For that 
reason, for analysis of expression of these genes, a sensitive method should be 
selected. In view of the fact that gelatinolytic activity was not perceptible by 
zymography, investigation was conduced in order to examine MMP-9 
expression. 
Reverse transcription coupled with polymerase chain reaction (RT-PCR) is a 
method developed after hybridisation-based techniques have been applied to 
expression analysis204, and one of its remarking features is the high sensitivity, 
which is provided by the amplification step. The RT-PCR technique allows 
several modifications that can be followed to estimate absolute or relative 
quantities of mRNA’s. In relative quantitative RT-PCR (also termed semi-
quantitative RT-PCR) an internal standard, usually cDNA from mRNA of a 
housekeeping gene, is co-amplified with the target cDNA in a non-competitive 
fashion and relative amounts of the target mRNA are obtained by comparing 
with the internal standard amplicon205,206,207. Relative quantitative RT-PCR was 
used to study the expression of MMP-2 and MMP-9 and their natural inhibitors, 
TIMP-2 and TIMP-1, respectively. Primers for reverse transcriptase reaction were 
specific to the poli-A tail (Oligo-dT primer) to allow the consequent 
quantification of mRNA.  
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Before cDNA synthesis RNA quantity and purity was assessed by measurement 
of OD260/280 (as described in Material & Methods of this chapter) and by gel 
electrophoresis. In Fig. 4.3 is represented an example of RNA samples that have 
been selected for cDNA synthesis reactions.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 – Quality assessment of total RNA extracted from embryonic cortical neuronal cultures. 
The samples were run on 1.5% denaturing agarose gel. The 28S and 18S ribosomal RNA bands are 
clearly visible (arrows). There is no contamination with genomic DNA and it is possible to visualise 
a smear band that corresponds to the 5S of tRNA. Molecular weight marker used: Gene RulerTM, 
100bp DNA ladder plus (Fermentas). 
 
 
After cDNA synthesis, the samples were used for co-amplification of the target 
and the housekeeping genes. In Fig. 4.4-A is shown a representative gel 
electrophoresis of TIMP-2 expression performed as described under “Material & 
Methods” section; the multiplex RT-PCR produced a 308-base pair TIMP-2 
fragment and a 490-base pair β-actin fragment with similar staining intensities. 
Densitometric analyses were carried out to determine the OD ratios of each 
lane on every performed gel. The final results are summarised on the graphical 
representation in Fig. 4.4-B/C. Interestly, multiplex RT-PCR results for MMP-2 and 
MMP-9 expression on the first day of culture are significantly different between 
the two isolation procedures achieving the highest levels on the neuronal 
cultures established with cardosins. 
 
 
 
 
28S 
18S 
5S 
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Figure 4.4 - Expression of MMPs and TIMPs on both neuronal cultures types (cardosins versus 
trypsin): A - representative gel electroforesis of TIMP-2 expression performed as described under 
“Material and Methods” section; the multiplex RT-PCR produced a 308-base pair TIMP-2 fragment 
and a 490-base pair β actin fragment with similar staining intensities. B) mRNA expression of 
MMP-2 and TIMP-2; C) mRNA expression of MMP-9 and TIMP-1. Expression values are expressed as 
ratio target gene/β-actin.  
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There are no major differences on the expression after 4 and 7 days on culture 
for both gelatinases. 
The same is observed for TIMP-2 expression that is equally expressed during all 
experiments. In contrast, the homogeneity of the results of TIMP-1 mRNA 
expression is broken at the fourth day. As it can be observed, TIMP-1 expression 
by neuron isolated with trypsin is extremely high when compared to cultures 
established with cardosins. 
Laminin is an important ECM protein that has been found to be involved in 
cellular activities such as neuronal migration and neurite outgrowth. To get 
further insights of ECM expression and since laminin is an extracellular protein 
that has been described as a key element on neuronal permissivity198, besides 
MMPs protein level determination by western blot, laminin protein level was also 
assessed (Fig. 4.5). β-actin was used as an internal loading control. The results for 
MMP-2 and MMP-9 are consistent since the major differences are found at the 
first day of culture incubation. In fact, the protein expression for both 
gelatinases is much higher for neuron isolated with cardosins after the first 24 
hours. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 - Protein expression levels on both types of rat embryonic cell cultures (cardosins versus 
trypsin) assessed by western blot analysis for laminin; MMP-9: the weak band corresponds to the 
active form (82kDa), whereas the strong one corresponds to pro-MMP-9 (92kDa)and MMP-2: only 
the active form of MMP-2 was detected (60kDa). β-actin was used as a loading control.  
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A high level of laminin constitutes central permissive elements that can be 
modulated by proteolytic activity. The immunoblotting analysis detected a 
200-220kDa protein band appropriate to be the size of laminin β/γ chains. 
Generally, during 7 days in culture neurons isolated with cardosins are 
expressing higher levels of laminin then neurons isolated with trypsin. Even 
though, after 24 hours laminin level did not vary, significantly, between the two 
types of culture, suggesting that this protein amount could be determinant for 
cell recovery from both isolation procedures. Nevertheless, 
immunocytochemistry analysis did not reveal significant differences of laminin 
distribution in both types of culture. In Fig. 4.6 it is represented an example of 
immunocytochemistry images obtained by double labelling studies using 
anti-MAP-2 and anti-laminin antibodies.  
     
 
4.3.2 Anti-laminin and RGD effect on permissivity to neuritogenesis 
  
Laminin bioavailability has been described as an important permissive factor for 
neuronal migration and neurite outgrowth, including postlesion 
situations198,208,209,210. 
In an effort to verify the ability of cell response mechanisms for both culture 
types, 7 days mechanically lesioned neuron-cortical cultures were treated with 
an anti-pan-laminin antibody to inhibit outgrowth and neuronal migration in the 
vicinity of a mechanical lesion.  
This treatment, reported by Costa and co-workers198 (2002), blocks substantial 
portion of neurite outgrowth and induces an apparent inhibition of neuronal 
migration toward the lesion site.  This is plainly evident by analysing 
immunocitochemistry results where anti-laminin antibody has reduced neurite 
sprouting to the lesioned area. 
Actually, in Fig. 4.7-c/c’, immunocytochemistry analysis reveal that lesioned 
neuronal cultures that have been treated with anti-laminin antibody show an 
                                                          
208 Rivas Rj, Burmeister Dw, Goldberg Dj (1992). Rapid effects of laminin on the growth cone. Neuron 8: 107-
115. 
209 Mckeon Rj, Höke A, Silver J (1995). Injury-induced proteoglycans inhibit the potential for laminin-mediated 
axon growth on astrocytic scars. Exp Neurol 136: 32-43. 
210 Walsh JF, Manwaring ME, Tresco PA (2005). Directional neurite outgrowth is enhanced by engineered 
meningeal cell-coated substrates. Tissue Eng. 11(7-8): 1085-94. 
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accentuate reduction of neurite outgrowth inside the lesion area when 
compared with untreated cultures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 - Double immunofluorescence labelling of embryonic cortical neurons isolated with 
cardosins (A) or by trypsin (B). Cultured neurons for 4 days were double stained for MAP-2 (neuron 
marker, red) and for laminin (green) and consequently detected with Alexa 594-conjugated 
secondary anti-mouse antibody and with Alexa 488-conjugated secondary anti-rabbit antibody, 
respectively.  
 
 
A 
B 
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It has extensively been reported that ECM signalling is initiated by the 
interaction of distinct ECM sequences with specific cellular receptors. The best 
described family of ECM receptors corresponds to integrins that can interact 
with a number of ECM components211. In a few words, integrins are 
heterodimeric membrane proteins comprising one α and one β polypeptide 
chain. By using a large range of helper molecules, integrins connect the 
cytoplasm to the proteins on the outside of the cell212. But integrins are more 
than just adhesion molecules. They exert control over various signalling 
pathways to regulate virtually every aspect of cell behaviour. In cells in culture, 
integrins are often found in large complexes, or focal adhesions, aspects of 
which are thought to resemble the concentration of integrins found in 
juxtaposition to basement membranes. Over the past few years, evidence has 
emerged that integrins are crucial to brain development, yet the brain is largely 
devoid of classical basement membranes – it does, however, have extracellular 
matrix molecules213.  
The interaction between cell and ECM components can involve different 
peptide sequences within the ECM molecules, among them the RGD sequence 
(Arg-Gly-Asp) that is contained in laminin, fibronectin, and collagen IV214,215,216. 
Consequently, peptides containing RGD sequence can be used to block 
cellular adhesion to RGD sequences within substrata. Similar to integrins, RGD 
sequences may be involved not only in adhesion but also in the promotion of 
neurite outgrowth217. 
Therefore, parallel assays were performed by treating mechanically lesioned 
neuronal cultures with RGD peptide, instead of anti-laminin antibody. Fig. 4.7-
d/d’ (cardosins and trypsin prepared cultures, respectively) shows that RGD 
effect on neuronal regrowth is closely similar to the effect observed for 
anti-pan-laminin antibody.  
                                                          
211 Schwartz MA (2001). Integrin signaling revisited. Trends Cell Biol. 11(12): 466-70. Review. 
212 Van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res 2001; 305 (3): 285-298. 
213 Novak, U. and A.H. Kaye (2000). Extracellular matrix and the brain: components and function. Review. J. 
Clin. Neurosci. 7, 280-290. 
214 Yamada KM (1991). Adhesive recognition sequences. J. Biol. Chem. 266: 12809–12812. 
215 Ruoslahti, E. 1996. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 12: 697–715. 
216 Gruenbaum LM, Carew TJ (1999). Growth factor modulation of substrate-specific morphological patterns in 
Aplysia bag cell neurons. Learn Mem. 6(3): 292-306. 
217 Tashiro K, Sephel GC, Greatorex D, Sasaki M, Shirashi N, Martin GR, Kleinman HK, Yamada Y (1991). The RGD 
containing site of the mouse laminin A chain is active for cell attachment, spreading, migration and neurite 
outgrowth. J Cell Physiol. Mar;146(3):451-9. 
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Figure 4.7 – Blocking effect on permissivity to neuritogenesis (representative images of 
immunoscytochemistry). a and a’) initial lesion on a 7 days culture (control); b and b’) 24 h 
postlesion untreated culture. Observe the neurite outgrowth inside the lesion site compared with 
the control; c and c)   24 h postlesion treated culture with anti-laminin antibody (1/200). d and d’)   
24 h postlesion treated culture with RGD peptide (500µM).  In c) and d) is clear the reduction of 
neurites projecting toward the lesion. (scale bar = 100µm). Prepared cultures by cardosins (left 
column) or trypsin (right column) are indicated in the figure (Figure in the previous page). 
 
 
Gelatinase activity was also evaluated. Densitometric analysis of gelatine 
zymograms (data not shown), and as it can be confirmed in Fig. 4.8, have 
demonstrated that there is no evidence for different MMP-2 activity after 24 
hours of AL or RGD treatment. Three different samples of each experimental 
state (treated or untreated culture cells) revealed that there is homogeneity in 
the results. Once again MMP-9 gelatinolytic activity was not detected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8- Representative gelatin zymography of either untreated (control) or treated 
(anti-laminin antibody, AL and RGD peptide) neuronal cultures. There are no significant 
differences on active form of MMP-2 (arrows) activity.  
 
 
Mechanical lesioned neuronal cultures were also evaluated in terms of mRNA 
expression levels of ECM components that participate in axonal growth 
processing. It was previously mentioned that there are several evidences that 
MMPs and TIMPs constitute key elements on the nervous system regeneration. 
As well, it as been described that both TIMP-1 and TIMP-2 display growth 
promoting in a wide variety of cell types218,219,220. 
                                                          
218 Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. 1994. Cell growth-promoting activity of tissue inhibitor 
of metalloproteinase-2 (TIMP-2). J Cell Sci 107:2373–2379. 
219 Bertaux B, Hornbeck W, Eisen AZ, Dubertret L. 1991. Growth stimulation of human keratinocytes by tissue 
inhibitor of metalloproteinases.J Invest Dermatol 97:679–685. 
220 Stetler-Stevenson WG, Bersch N, Golde DW. 1992. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has 
erythroid-potentiating activity. FEBS Lett 296:231–234. 
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Accordingly, mRNA expression of gelatinases A (MMP-2) and B (MMP-9), and 
TIMP-2 and TIMP-1 (their respective inhibitors) were determined by 
semi-quantitative RT-PCR.  The results of mRNA expression 24 hours after lesion 
show that treatment with anti-laminin antibody led to up regulated TIMP-1 and 
MMP-9 expression while differences on TIMP-2 and MMP-2 mRNA expression 
were not detected (Fig. 4.8). The same neuronal behaviour is observed for the 
treatment with RGD peptide. In fact, only MMP-9 and TIMP-1 mRNA expressions 
are induced. 
 
 
 
Figure 4.9 - Densitometric results from semi-quantitative RT-PCR analysis (mean ± standard 
deviation). Effect of anti-laminin and RGD addition to conditioned medium on mRNA expression 
of MMP-2, TIMP-2, MMP-9 and TIMP-1. Neuronal cultures established with cardosins (green bars) or 
established with trypsin (red bars) (n = 3). **P < 0.01, *P < 0.05.  
 
 
 
At last, it is notable an increase of the extracellular laminin level for both AL and 
RGD treated cultures established either with cardosins or trypsin. The graphical 
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representation in Fig. 4.10, results from data analysis of immunodetection using 
anti-laminin antibody.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 - Laminin quantification assessed by western blot analysis, (n = 3). *P < 0.05. All the 
described analysis were performed in parallel on both culture types (cardosins versus trypsin) 
showing the same results.  
 
These results are probably associated to cell response to injury, by expressing 
laminin cells are producing permissive conditions that enhance neuronal 
growth. The present investigation sustains the idea that ECM plays a vital role in 
mediating axonal regeneration following brain disaggregation for 
establishment of primary cell cultures. Since, ECM regeneration is achieved by 
MMPs activity over matrix or non-matrix proteins - that direct or indirect are 
responsible for the rebuilt of the new network – the focal point of this 
investigation was to obtain the expression pattern and enzymatic activity of 
these molecules, after cardosins application for neuronal dissociation.  
In resume, cell responses to injury, on both culture types, were comparable for 
mRNA expression of MMPs/TIMPs and for activity, suggesting equal cell 
morphology and functionality, after 7 days in culture. 
Previous studies of Reeves and colleagues suggested a potentially functional 
role of MMP-2 in post-lesion axonal sprouting and neuronal plasticity by 
reporting that differentiation and subsequent functional plastic recovery is 
correlated with increased MMP-2 activity199. As well, during brain 
disaggregation each neuron is strained to disrupt connections to the neighbour 
cells resulting in a recovery-like cell response. MMP-2 expression and activity 
levels after 1 day of culture establishment are higher for cultures obtained with 
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cardosins than for trypsin cultures, suggesting that cell response to isolation 
procedure is faster for neurons isolates with cardosin. These results support 
morphological examination, previously shown in the last chapter that has 
demonstrated a superior number and length of neurites in cultures established 
with cardosins. Collectively, the results at 1 day in culture show a substantiate 
improvement on isolation protocol by using cardosins instead of trypsin. 
Expression results for MMPs inhibitors corroborate previous findings that TIMP-2 
expression increases throughout development and is maintained at high levels 
into adulthood221,222,223. Moreover, the primary function of TIMPs is to inhibit MMP 
activity, consequently TIMP-1 and TIMP-2 expression may be upregulated simply 
in response to increased MMP expression.  
As far as the possible function of TIMP-1 in the brain is concerned, very little is 
known. However, it should be noted that this protein delivered in an adenoviral 
vector was capable of inhibiting excitotoxic cell death in cultured neurons224 
acting by a mechanism of neuroprotection. 
The facts that TIMP-1 expression is associated with neuronal plasticity and that 
trypsin seems to be more aggressive to neurons during isolation procedure than 
cardosins, could explain the huge TIMP-1 mRNA expression obtained at the 
fourth day of culture for neurons obtained with trypsin.   
It is well known that after injury, neurons do not spontaneously regenerate their 
axons, largely due to the inhibitory post-lesion environment that impedes 
regrowth on multiple levels. In the 1980s Aguayo and colleagues provided 
injured neurons in the brain and spinal cord with peripheral nerve grafts, and 
demonstrated that CNS neurons retain the capacity for regrowth when 
provided with an appropriate, permissive environment225,226. These guidance 
                                                          
221 Fager N, Jaworski DM (2000) Differential spatial distribution and temporal regulation of tissue inhibitor of 
metalloproteinase mRNA expression during rat central nervous system development. Mech Dev 98: 105-109. 
222
 Pérez-Martínez L, Jaworski DM (2005) Tissue Inhibitor of Metalloproteinase-2 Promotes Neuronal 
Differentiation by Acting as an Anti-Mitogenic Signal. J Neurosci 25(20):4917-4929) 
223 Young DA, Phillips BW, Lundy C, Nuttall RK, Hogan A, Schultz GA, Leco KJ, Clark IM, Edwards DR (2002) 
Identification of an initiator-like element essential for the expression of the tissue inhibitor of 
metalloproteinases-4 (Timp-4) gene. Biochem J 364: 89-99. 
224 Tan HK, Heywood D, Ralph GS, Bienemann A, Baker AH, Uney JB (2003). Tissue inhibitor of metalloproteinase 
1 inhibits excitotoxic cell death in neurons. Mol. Cell Neurosci. 22, 98–106. 
225 Aguayo AJ, David S, Bray GM. Influences of the glial environment on the elongation of axons after injury: 
transplantation studies in adult rodents. J Exp Biol 1981;95:231–40. 
226 Bray GM, Vidal-Sanz M, Aguayo AJ. Regeneration of axons from the central nervous system of adult rats. 
Prog Brain Res 1987;71:373–9. 
 
 
4. MMPs in the mechanisms of neuronal regeneration and recovery 
cues are modulated by MMPs activity nevertheless further insights are needed 
to clarify specific roles of MMPs on permissivity.  
In the present study, after 7 days in culture communication between viable 
cells was interrupted by mechanical lesion and re-growth of neurites and the 
expression of ECM proteins was measure in both types of cultures. No significant 
differences on the number and length of the neurites were detected. Neuronal 
response to CNS insults operates by selectively enhance MMP activities that 
improve recovery mechanisms and display neuroprotection pathways. As 
expected, after injury, both MMP-9 and TIMP-1 are over expressed. Although it 
has not been clarify whether MMP-9 is expressed by the neurons prone to death 
and/or those attempting to recover from the damage, it was described a 
potential connection(s) with neuronal survival, synaptogenesis and MMP-9227, 
that supports presented data.  
Following nerve injury, there is a rapid upregulation of many ECM proteins, 
including fibronectin228,229 and laminin230. Experiments utilising function-blocking 
antibodies have highlighted the essential role laminin plays in promoting axonal 
regeneration231,232 as it could be evaluated after morphological analysis. 
MMPs are regulated after some types of insult, such as cell isolation or 
mechanical lesion180. With respect to cell migration, neural cell precursors may 
require balanced MMP activities in order to migrate to the scarred area. New 
axonal growth and synaptic reconnections need to be established and their 
extension through the brain matrix may also require a new MMPs/TIMPs ratio. An 
increase of MMP-9 and TIMP-1 expression level was evident. This new balance 
must contribute directly or indirectly to the increased laminin expression, which 
assists regrowth permissivity. 
In addition to the effects on expression/activity of MMPs, it was also observed 
the effect of the pan-laminin antibody and the effect of RGD peptide on the 
morphology of cortical neurons. Surprisingly, the anti-laminin antibody 
                                                          
227 Joanna Dzwonek, Marcin Rylski, Leszek Kaczmarek (2004) Matrix metalloproteinases and their endogenous 
inhibitorsin neuronal physiology of the adult brain. Review 
228 F. Lefcort, K. Venstrom, J.A. McDonald and L.F. Reichardt, Regulation of expression of fibronectin and its 
receptor, alpha 5 beta 1, during development and regeneration of peripheral nerve, Development 116 
(1992), pp. 767–782. 
229 M.G. Vogelezang, S.S. Scherer, J.W. Fawcett and C. ffrench-Constant, Regulation of fibronectin alternative 
splicing during peripheral nerve repair, J. Neurosci. Res. 56 (1999), pp. 323–333. 
230 W. Wallquist, M. Patarroyo, S. Thams, T. Carlstedt, B. Stark, S. Cullheim and H. Hammarberg, Laminin chains 
in rat and human peripheral nerve: distribution and regulation during development and after axonal injury, J. 
Comp. Neurol. 454 (2002), pp. 284–293. 
231 E. Agius and P. Cochard, Comparison of neurite outgrowth induced by intact and injured sciatic nerves: a 
confocal and functional analysis, J. Neurosci. 18 (1988), pp. 328–338. 
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modulated neuronal morphology in a pattern very similar to the effects of RGD 
sequence: both treatments led to a decrease of neurite outgrowth in the 
scared area. Moreover, as it can be confirmed in Fig. 4.10, RGD treatment 
promotes laminin over-expression. One speculation arising from these 
observations is that both type of cultures (established with cardosins or with 
trypsin) act in response to the described stress conditions via laminin expression, 
by other words, neurons overcome injury by favouring permissivity. Finally, these 
data suggest that cortical neurons use RGD-dependent mechanisms for 
adhesion and outgrowth, witch provides possible sites of modulation by specific 
growth factors, since ECM components can act not only as passive substrates 
for neuronal attachment and outgrowth but also as active sites for signal 
transduction. 
                                                                                                                                                                          
232 C. Ide, Peripheral nerve regeneration, Neurosci. Res. 25 (1996), pp. 101–121. 
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The results described in the present research study show that cardosins can be 
used to dissociate neuronal tissue to prepare cell cultures.  
 
These aspartic proteases of plant origin allow to obtain a large number of cells, 
as it is achieved by using trypsin, nevertheless, this work demonstrates that 
cardosins use most certainly guaranties homogenous results. This is probably 
due to high reproducibility of cardosins purification mixture in contrast with 
different batches of commercial trypsin that frequently exhibit dissimilar 
enzymatic activities.  
 
Cell yield and viability, and the composition in neuronal and glial cells were 
comparable to those obtained with trypsin digestion, but slight increase on 
neuronal recover after cell plating suggesting that proteolytic activity of 
cardosins, during tissue dissociation, follows a mechanism that is less aggressive 
to neurons than trypsin. This feature is, most likely, associated to a more restrict 
specificity of cardosins.  
 
The results emphasise the significance of the enzymatic influence evaluation on 
isolation procedures, given that different enzymes can produce divergent 
effects on cell morphology and function by stimulating or inhibiting cell 
response. As different enzyme can produce different cell preparation, it seems 
that is important to do a pondered choice of enzymatic tool to achieve 
maximal cellular reliance.   
 
Moreover, the cells isolated with cardosins are suitable for functional studies as 
neurotransmitter release and response to toxic injury. 
 
The present study has demonstrated that MMPs regulation level can help to 
predict the cellular developing state, in terms of axonal growth and elongation, 
suggesting that MMPs should be viewed, not only as proteolytic enzymes acting 
on ECM remodelling but, overall, performing as pruning shears, playing 
5. Main conclusions 
sophisticated roles in modulating normal cellular behaviour, cell–cell 
communication and tumour progression. 
 
Actually, taking advantages of the increase on MMPs findings, these enzymes 
could be used as valuable tool to forecast cell behaviour and cell functional 
state. The broadly MMPs involvement in cell regulation mechanisms can be 
particularly helpful, to investigate, for instance, the effect of pharmaceutical 
drugs to be used in the treatment of several diseases, where MMPs might 
perform in an injurious manner. 
 
As final remark, this investigation points towards cardosins application for 
autotransplantation procedures, as cell culture manipulation would preserve 
cell integrity, leading to a faster patient rehabilitation. 
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The present work describes a combined enzymatic and mechanical method 
that has been optimised for rat cortex neuronal isolation for establishment of 
primary cell culture.  
The cell yield and the physiologic condition of the neurons obtained using the 
isolation procedures applied during this study allows the application of these 
cells for diverse purposes, concerning different areas of investigation, for 
example, citochemistry, electrophysiology, neurotoxicology, pharmacology 
and therapeutics, offering greater reliance when compared to other methods, 
which did not include the characterization of the isolated cells were not 
characterised.  
Clearly the use of cardosins for neuronal isolation allows obtaining cell cultures 
characterized by normal cellular growth. 
Furthermore, this report raises the possibility of the application of cardosins for 
the isolation of other types of cells, taking advantage of their combined 
collagenolytic/gelatinolytic activity, which could be especially useful for tissues 
with a high content of collagen. Trypsin has been shown to be less efficient in 
those cases and collagenases are more expensive since they require a 
multi-step purification method. In contrast, the cardosins mix is obtained by a 
single-step purification method that yields, approximately, 10 mg of enzyme, 
corresponding to 5 isolation procedures. Moreover, the preparation of the 
cardosins can be stored as lyophilised powder. Therefore, these aspartic 
proteinases, by themselves or in combination with other enzymes, constitute a 
motivating target on cell investigation, opening new avenues for cell isolation in 
tissues where other enzymes were not efficient. 
Finally, cardosins can be proposed as an alternative enzymatic tool for 
subcultivation procedures, on the establishment of finite cultures and 
continuous cell lines, since it has been demonstrated at this point that the use 
of cardosins induces less cellular damage. This feature is, most likely, associated 
to a more restrict specificity of cardosins, since these aspartic proteinases are 
characterised for hydrolysing peptide bonds between large and hydrophobic 
residues. Recent in vitro studies have shown that cardosins can hydrolyse 
6. Future prospects 
collagens by cleaving the molecule in some specific peptide bonds233, which 
supports for cardosins behaviour during cell dissociation from tissues.     
The early cell recovery to isolation procedure seems to be related to the narrow 
specificity of cardosins that supports their application for establishment of 
primary cell culture and for subcultivation procedures. In this sense, cardosins 
activity can be particularly interesting for auto-transplantation procedures, as 
cell culture manipulation would preserve cell integrity, leading to a faster 
patient rehabilitation. 
On the topic of cardosins applications some aspects have to be considered for 
prospective reflection. Recombinant cardosin A should be characterized 
following the strategy applied during this study and the results compared with 
those obtained with the natural extract of cardosins. Data obtained will be 
essential to evaluate the commercial potential of this enzyme.  
 
                                                          
233 Duarte AS, Pereira A, Cabrita AS, Moir A, Pires E, Barros, M (2005). The characterisation of the collagenolytic 
activity of cardosin A demonstrates its potential application for extracellular matrix degradative processes. 
Current Drug Discovery Technologies. Vol. 2, Issue 1, 37-44. 
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Table 7.1 - Basal and induced MMP expression in the brain (adapted from J. Dzwonek et al., 2004.) 
 
Gene  Brain structure  Expression   
    Basal level  Upregulation (↑) / Downregulation (↓) 
 
MMP-2 
  
Hippocampus 
 
 
 
 
 
 
Cortex 
 
 
 
Cerebellum 
 
 
Substantia nigra  
 
Pons 
 
  
Uniformly distributed, 
gray matter, astrocytes 
 
 
 
 
 
Astroglia, some neurons  
 
 
 
Purkinje cells  
 
  
Unaffected by spatial learning 
Seizures (3–7 days) (↑) 
Sprouting  (↑) 
Traumatic brain injury  (↑) 
Transient ischemia  (↑) 
Early phase of CDV infection  (↑) 
 
Seizures (3–7 days) (↑) 
Transient ischemia  (↑) 
ALS (↓) 
 
Changes during postnatal development 
 
 
Parkinson’s disease (↓) 
 
Spinocerebellar ataxia type 3  (↑) 
 
 
MMP-3 
 
  
Cortex 
 
 
Cerebellum 
 
  
 
 
 
Neurons, cell bodies, 
Bergman glia fibers 
 
  
Transient ischemia  (↑) 
Traumatic brain injury  (↑) 
 
Changes during postnatal development 
 
MMP-7 
 
  
Brain 
 
  
More than three orders 
of magnitude less than 
MMP-9 
 
  
 
MMP-8 
 
  
Brain 
 
  
Two orders of magnitude 
less than MMP-9 
 
  
 
MMP-9 
 
  
Hippocampus 
 
 
 
 
 
 
Cortex 
 
 
 
 
 
 
 
Cerebellum 
 
  
Pyramidal and granular 
neurons, cell bodies and 
dendrites 
 
 
 
 
Cortical neurons 
(cytoplasm and 
apical dendrites), white 
matter KCl 
 
 
 
 
Neurons, granule cell 
precursors, 
cell bodies, Bergman 
glial processes 
 
 
  
Seizures (neurons, dendrites, astrocytes) (↑) 
Spatial learning (↑) 
Sleep deprivation (↓) 
Alzheimer’s disease  (↑) 
Early phase of CDV infection  (↑)  
Transient ischemia  (↑)   
 
Seizures  (↑) 
Spatial learning  (↑) 
Depolarization (neurons) (↑)   
Modulated by sleep  
Cerebral contusion  (↑) 
ALS (↓) 
Transient ischemia  (↑) 
 
Changes during postnatal development  
 
 
 
 
 
 
 
MMP-10 
 
  
Brain 
 
  
Two orders of magnitude 
less than 
MMP-9 
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Gene  Brain structure  Expression   
    Basal level  Upregulation (↑) / Downregulation (↓) 
 
MMP-14 
 
  
Cortex  
 
Hypothalamus  
 
    
Early phase of CDV infection  (↑)   
 
Early phase of CDV infection  (↑) 
 
MMP-15 
 
  
Brain 
 
  
Similar amount to MMP-9  
 
  
 
MMP-16 
 
  
Brain 
 
  
Similar amount to MMP-9 
 
  
 
MMP-24 
 
  
Hippocampus  
 
 
Cortex  
 
Cerebellum  
 
  
Pyramidal and granular 
neurons 
 
Neurons 
 
Neurons, cell bodies and 
dendrites 
  
Changes during postnatal development  
 
 
Changes during postnatal development  
 
Changes during postnatal development 
 
 
ALS, amyotrophic lateral sclerosis; CDV, canine distemper virus 
 
 
Table 7.2 - Basal and induced TIMP expression in the brain (adapted from J. Dzwonek et al., 2004.) 
 
Gene  Brain structure  Expression   
    Basal level  Upregulation (↑) / Downregulation (↓) 
 
TIMP-1  
 
  
Hippocampus  
 
 
 
 
 
 
 
 
Cortex 
 
 
 
 
Cerebellum  
 
 
Substantia nigra 
  
Pyramidal and granular 
neurons, cell bodies 
and dendrites 
 
 
 
 
 
 
Neurons, not astrocytes  
 
 
 
 
Neurons, Bergman glial 
cells 
  
Seizures (neurons, astrocytes) (↑) 
ECS (DG, molecular layer of DG) (↑) 
Early phase of CDV infection  
Transient ischemia  (↑) 
Experimental autoimmune encephalitis  (↑) 
Human T-lymphotropic virus type I infect  (↑)  
Human immunode.ciency 1-associated 
dementia  (↑) 
 
KCl depolarization (neurons) (↑) 
ECS (outer layer of the cerebral cortex) (↑) 
Early phase of CDV infection  (↑)  
Cerebral contusion  (↑) 
 
Changes during postnatal development 
Hypothalamus Early phase of CDV infection  
(↑)  
 
Parkinson’s disease  (↑) 
 
TIMP-2  
 
  
Cortex 
 
Cerebellum 
  
Predominantly neurons  
 
Neurons 
  
Unaffected by KCl depolarization 
 
Changes during postnatal development 
 
 
TIMP-3  
 
  
Cortex 
 
 
 
Cerebellum 
  
Predominantly neurons  
 
 
 
Neurons, dendrites, cell 
bodies 
  
Unaffected by KCl depolarization  
Early phase of CDV infection in mousea  (↑) 
Transient ischemia  (↑) 
 
Changes during postnatal development  
 
 
TIMP-4  
 
  
Cerebellum 
  
Purkinje cells 
  
Changes during postnatal development  
CDV, Canine distemper virus; DG, dentate gyrus; ECS, electroconvulsive shock. 
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ECM PROTEIN SEQUENCE ANALYSIS 
 
MDRVRFKASGPPLRGWLLLATVTVGLLAQSVLGGVKKLDVPCGGRDCSGGCQCYPEKGARGQPGAVGPQG 
YNGPPGLQGFPGLQGRKGDKGERGVPGPTGPKGDVGARGVSGFPGADGIPGHPGQGGPRGRPGYDGCNGT 
RGDAGPQGPSGSGGFPGLPGPQGPKGQKGEPYALSKEDRDKYRGEPGEPGLVGYQGPPGRPGPIGQMGPM 
GAPGRPGPPGPPGPKGQPGNRGLGFYGQKGEKGDIGQPGPNGIPSDITLVGPTTSTIHPDLYKGEKGDEG 
EQGIPGVISKGEEGIMGFPGIRGFPGLDGEKGVVGQKGSRGLDGFQGPSGPRGPKGERGEQGPPGPSVYS 
PHPSLAKGARGDPGFQGAHGEPGSRGEPGEPGTAGPPGPSVGDEDSMRGLPGEMGPKGFSGEPGSPARYL 
GPPGADGRPGPQGVPGPAGPPGPDGFLFGLKGSEGRVGYPGPSGFPGTRGQKGWKGEAGDCQCGQVIGGL 
PGLPGPKGFPGVNGELGKKGDQGDPGLHGIPGFPGFKGAPGVAGAPGPKGIKGDSRTITTKGERGQPGIP 
GVHGMKGDDGVPGRDGLDGFPGLPGPPGDGIKGPPGDAGLPGVPGTKGFPGDIGPPGQGLPGPKGRRGFP 
GDAGLPGPPGFPGPPGPPGTPGQRDCDTGVKRPIGGGQQVVVQPGCIEGPTGSPGQPGPPGPTGAKGVRG 
MPGFPGASGEQGLKGFPGDPGREGFPGPPGFMGPRGSKGTTGLPGPDGPPGPIGLPGPAGPPGDRGIPGE 
VLGAQPGTRGDAGLPGQPGLKGLPGETGAPGFRGSQGMPGMPGLKGQPGFPGPSGQPGQSGPPGQHAFPG 
TPGREGPLGQPGSPGLGGLPGDRGEPGDPGVPGPVGMKGLSGDRGDAGMSGERGHPGSPGFKGMAGMPGI 
PGQKGDRGSPGMDGFQGMLGLKGRQGFPGTKGEAGFFGVPGLKGLPGEPGVKGNRGDRGPPGPPPLILPG 
MKDIKGEKGDEGPMGLKGYLGLKGIQGMPGVPGVSGFPGLPGRPGFIKGVKGDIGVPGTPGLPGFPGVSG 
PPGITGFPGFTGSRGEKGTPGVAGVFGETGPTGDFGDIGDTVDLPGSPGLKGERGITGIPGLKGFFGEKG 
AAGDIGFPGITGMAGAQGSPGLKGQTGFPGLTGLQGPQGEPGRIGIPGDKGDFGWPGVPGLPGFPGIRGI 
SGLHGLPGTKGFPGSPGVDAHGDPGFPGPTGDRGDRGEANTLPGPVGVPGQKGERGTPGERGPAGSPGLQ 
GFPGISPPSNISGSPGDVGAPGIFGLQGYQGPPGPPGPNALPGIKGDEGSSGAAGFPGQKGWVGDPGPQG 
QPGVLGLPGEKGPKGEQGFMGNTGPSGAVGDRGPKGPKGDQGFPGAPGSMGSPGIPGIPQKIAVQPGTLG 
PQGRRGLPGALGEIGPQGPPGDPGFRGAPGKAGPQGRGGVSAVPGFRGDQGPMGHQGPVGQEGEPGRPGS 
PGLPGMPGRSVSIGYLLVKHSQTDQEPMCPVGMNKLWSGYSLLYFEGQEKAHNQDLGLAGSCLARFSTMP 
FLYCNPGDVCYYASRNDKSYWLSTTAPLPMMPVAEEEIKPYISRCSVCEAPAVAIAVHSQDTSIPHCPAG 
WRSLWIGYSFLMYTAAGDEGGGQSLVSPGSCLEDFRATPFIECNGGRGTCHYFANKYSFWLTTIPEQNFQ 
STPSADTLKAGLIRTHISRCQVCMKNL 
 
Figure 7.1 - Sequence of procollagen, type IV, alpha 2 (Mus musculus, NP_034062.2). Identification of 
hypothetical cleavage sites for cardosins (dark green) - based on their known primary specificity (F-V, 
L-Y, L-V, F-Y, F-M, L-T, L-S, Y-L, FF, IY) and cleavage peptide bonds for trypsin (red). Light green label 
peptide bond (FQ) corresponds to a cleavage site identified for type I collagen by cardosins A. 
 
 
 
MPALWLSCCLGVALLLPAAQATSRREVCDCNGKSRQCVFDQELHRQTGSGFRCLNCNDNTAGVHCERCRE 
GFYRHRDRDRCLPCNCHSKGSLSAGCDNSGQCRCKPGVTGQRCDRCQPGFHMLTDAGCTRDQGQLDSKCD 
CDPAGISGPCDSGRCVCKPAVTGERCDRCRPGYYHLDRANPEGCTQCFCYGHSASCHASADFSVHKITST 
FSQDVDGWKAVQRNGAPAKLHWSQRHRDVFSSARRSDPVYFVAPAKFLGNQQVSYGQSLSFDYRVDRGGR 
QPSAYDVILEGAGLQIRAPLMAPGKTLPCGITKTYTFRLNEHPSSHWSPQLSYFEYRRLLRNLTALLIRA 
TYGEYSTGYIDNVTLVSARPVSGAPAPWVERCVCPAGYKGQFCQECASGYKRDSARLGPFGACVPCNCQG 
GGACDPDTGDCYSGDENPDIECADCPIGFYNDPHDPRSCKPCPCHNGFSCSVMPETEEVVCNNCPPGVTG 
ARCELCADGFFGDPFGERGPVRPCQRCQCNNNVDPNASGNCDQLTGRCLKCIYNTAGVYCDQCKAGYFGD 
PLAPNPADKCRACNCSPMGSEPGECRGDGSCVCKPGFGGLNCDHAALTSCPACYNQVKIQMDQFTQQLQS 
LEALVSKAQGGGGGGTVPVQLEGRIEQAEQALQDILGEAQISEGAMRAVAVRLAKARSQENDYKTRLDDL 
KMTAERIRALGSQHQNRVQDTSRLISQMRLSLAGSEALLENTNIHSSEHYVGPNDFKSLAQEATRKADSH 
AESANAMKQLARETEDYSKQALSLARKLLSGGGGSGSWDSSVVQGLMGKLEKTKSLSQQLSLEGTQADIE 
ADRSYQHSLRLLDSASQLQGVSDLSFQVEAKRIRQKADSLSNLVTRQTDAFTRVRNNLGNWEKETRQLLQ 
TGKDRRQTSDQLLSRANLAKNRAQEALSMGNATFYEVENILKNLREFDLQVEDRKAEAEEAMKRLSSISQ 
KVADASDKTQQAETALGSATADTQRAKNAAREALEISSEIELEIGSLNLEANVTADGALAMEKGTATLKS 
EMREMIELARKELEFDTDKDTVQLVITEAQQADARATSAGVTIQDTLNTLDGILHLIDQPGSVDEEGMML 
LEQGLFQAKTQINSRLRPLMSDLEERVRRQRNHLHLLETSIDGILADVKNLENIRDNLPPGCYNTQALEQ 
Q 
 
Figure 7.2 - Sequence of mouse laminin gamma-2 chain precursor, 100kDa subunit (Q61092). Peptide 
bond labelling as described in legend of Fig. 7.1. 
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MRGSGTGAALLVLLASVLWVTVRSQQRGLFPAILNLATNAHISANATCGEKGPEMFCKLVEHVPGRPVRH 
AQCRVCDGNSTNPRERHPISHAIDGTNNWWQSPSIQNGREYHWVTVTLDLRQVFQVAYIIIKAANAPRPG 
NWILERSVDGVKFKPWQYYAVSDTECLTRYKITPRRGPPTYRADNEVICTSYYSKLVPLEHGEIHTSLIN 
GRPSADDPSPQLLEFTSARYIRLRLQRIRTLNADLMTLSHRDLRDLDPIVTRRYYYSIKDISVGGMCICY 
GHASSCPWDEEAKQLQCQCEHNTCGESCDRCCPGYHQQPWRPGTISSGNECEECNCHNKAKDCYYDSSVA 
KERRSLNTAGQYSGGGVCVNCSQNTTGINCETCIDQYYRPHKVSPYDDHPCRPCNCDPVGSLSSVCIKDD 
RHADLANGKWPGQCPCRKGYAGDKCDRCQFGYRGFPNCIPCDCRTVGSLNEDPCIEPCLCKKNVEGKNCD 
RCKPGFYNLKERNPEGCSECFCFGVSGVCDSLTWSISQVTNMSGWLVTDLMSTNKIRSQQDVLGGHRQIS 
INNTAVMQRLTSTYYWAAPEAYLGNKLTAFGGFLKYTVSYDIPVETVDSDLMSHADIIIKGNGLTISTRA 
EGLSLQPYEEYFNVVRLVPENFRDFNTRREIDRDQLMTVLANVTHLLIRANYNSAKMALYRLDSVSLDIA 
SPNAIDLAVAADVEHCECPQGYTGTSCEACLPGYYRVDGILFGGICQPCECHGHASECDIHGICSVCTHN 
TTGDHCEQCLPGFYGTPSRGTPGDCQPCACPLSIDSNNFSPTCHLTDGEEVVCDQCAPGYSGSWCERCAD 
GYYGNPTVPGGTCVPCNCSGNVDPLEAGHCDSVTGECLKCLWNTDGAHCERCADGFYGDAVTAKNCRACD 
CHENGSLSGVCHLETGLCDCKPHVTGQQCDQCLSGYYGLDTGLGCVPCNCSVEGSVSDNCTEEGQCHCGP 
GVSGKQCDRCSHGFYAFQDGGCTPCDCAHTQNNCDPASGECLCPPHTQGLKCEECEEAYWGLDPEQGCQA 
CNCSAVGSTSAQCDVLSGHCPCKKGFGGQSCHQCSLGYRSFPDCVPCGCDLRGTLPDTCDLEQGLCSCSE 
DSGTCSCKENVVGPQCSKCQAGTFALRGDNPQGCSPCFCFGLSQLCSELEGYVRTLITLASDQPLLHVVS 
QSNLKGTIEGVHFQPPDTLLDAEAVRQHIYAEPFYWRLPKQFQGDQLLAYGGKLQYSVAFYSTLGTGTSN 
YEPQVLIKGGRARKHVIYMDAPAPENGVRQDYEVQMKEEFWKYFNSVSEKHVTHSDFMSVLSNIDYILIK 
ASYGQGLQQSRIANISMEVGRKAVELPAEGEAALLLELCVCPPGTAGHSCQDCAPGYYREKLPESGGRGP 
RPLLAPCVPCNCNNHSDVCDPETGKCLSCRDHTSGDHCELCASGYYGKVTGLPGDCTPCTCPHHPPFSFS 
PTCVVEGDSDFRCNACLPGYEGQYCERCSAGYHGNPRAAGGSCQTCDCNPQGSVHSDCDRASGQCVCKPG 
ATGLHCEKCLPRHILMESDCVSCDDDCVGPLLNDLDSVGDAVLSLNLTGVSPAPYGILENLENTTKYFQR 
YLIKENAKKIRAEIQLEGIAEQTENLQKELTRVLARHQKVNAEMERTSNGTQALATFIEQLHANIKEITE 
KVATLNQTARKDFQPPVSALQSMHQNISSLLGLIKERNFTEMQQNATLELKAAKDLLSRIQKRFQKPQEK 
LKALKEANSLLSNHSEKLQAAEELLKEAGSKTQESNLLLLLVKANLKEEFQEKKLRVQEEQNVTSELIAK 
GREWVDAAGTHTAAAQDTLTQLEHHRDELLLWARKIRSHVDDLVMQMSKRRARDLVHRAEQHASELQSRA 
GALDRDLENVRNVSLNATSAAHVHSNIQTLTEEAEMLAADAHKTANKTDLISESLASRGKAVLQRSSRFL 
KESVGTRRKQQGITMKLDELKNLTSQFQESVDNITKQANDSLAMLRESPGGMREKGRKARELAAAANESA 
VKTLEDVLALSLRVFNTSEDLSRVNATVQETNDLLHNSTMTTLLAGRKMKDMEMQANLLLDRLKPLKTLE 
ENLSRNLSEIKLLISRARKQAASIKVAVSADRDCIRAYQPQTSSTNYNTLILNVKTQEPDNLLFYLGSSS 
SSDFLAVEMRRGKVAFLWDLGSGSTRLEFPEVSINNNRWHSIYITRFGNMGSLSVKEASAAENPPVRTSK 
SPGPSKVLDINNSTLMFVGGLGGQIKKSPAVKVTHFKGCMGEAFLNGKSIGLWNYIEREGKCNGCFGSSQ 
NEDSSFHFDGSGYAMVEKTLRPTVTQIVILFSTFSPNGLLFYLASNGTKDFLSIELVRGRVKVMVDLGSG 
PLTLMTDRRYNNGTWYKIAFQRNRKQGLLAVFDAYDTSDKETKQGETPGAASDLNRLEKDLIYVGGLPHS 
KAVRKGVSSRSYVGCIKNLEISRSTFDLLRNSYGVRKGCALEPIQSVSFLRGGYVEMPPKSLSPESSLLA 
TFATKNSSGILLVALGKDAEEAGGAQAHVPFFSIMLLEGRIEVHVNSGDGTSLRKALLHAPTGSYSDGQE 
HSISLVRNRRVITIQVDENSPVEMKLGPLTEGKTIDISNLYIGGLPEDKATPMLKMRTSFHGCIKNVVLD 
AQLLDFTHATGSEQVELDTCLLAEEPMQSLHREHGELPPEPPTLPQPELCAVDTAPGYVAGAHQFGLSQN 
SHLVLPLNQSDVRKRLQVQLSIRTFASSGLIYYVAHQNQMDYATLQLQEGRLHFMFDLGKGRTKVSHPAL 
LSDGKWHTVKTEYIKRKAFMTVDGQESPSVTVVGNATTLDVERKLYLGGLPSHYRARNIGTITHSIPACI 
GEIMVNGQQLDKDRPLSASAVDRCYVVAQEGTFFEGSGYAALVKEGYKVRLDLNITLEFRTTSKNGVLLG 
ISSAKVDAIGLEIVDGKVLFHVNNGAGRITATYQPRAARALCDGKWHTLQAHKSKHRIVLTVDGNSVRAE 
SPHTHSTSADTNDPIYVGGYPAHIKQNCLSSRASFRGCVRNLRLSRGSQVQSLDLSRAFDLQGVFPHSCP 
GPEP 
 
Figure 7.3 - Sequence of mouse laminin alpha-1 chain precursor, laminin A chain (P19137). Peptide 
bond labelling as described in legend of Fig. 7.1. 
 
 
MAPLRPFFILALVAWVSLADQESCKGRCTQGFMASKKCQCDELCTYYQSCCADYMEQCKPQVTRGDVFTM 
PEDDYWSYDYVEEPKNNTNTGVQPENTSPPGDLNPRTDGTLKPTAFLDPEEQPSTPAPKVEQQEEILRPD 
TTDQGTPEFPEEELCSGKPFDAFTDLKNGSLFAFRGQYCYELDETAVRPGYPKLIQDVWGIEGPIDAAFT 
RINCQGKTYLFKGSQYWRFEDGVLDPGYPRNISEGFSGIPDNVDAAFALPAHRYSGRERVYFFKGKQYWE 
YEFQQQPSQEECEGSSLSAVFEHFALLQRDSWENIFELLFWGRSSDGAREPQFISRNWHGVPGKVDAAMA 
GRIYVTGSLSHSAQAKKQKSKRRSRKRYRSRRGRGHRRSQSSNSRRSSRSIWFSLFSSEESGLGTYNNYD 
YDMDWLVPATCEPIQSVYFFSGDKYYRVNLRTRRVDSVNPPYPRSIAQYWLGCPTSEK 
 
Figure 7.4 - Sequence of vitronectin (Mus musculus, NP_035837.1). Peptide bond labelling as described 
in legend of Fig. 7.1. 
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MLRGPGPGRLLLLAVLCLGTSVRCTEAGKSKRQAQQIVQPQSPVAVSQSKPGCFDNGKHYQINQQWERTY 
LGNALVCTCYGGSRGFNCESKPEPEETCFDKYTGNTYKVGDTYERPKDSMIWDCTCIGAGRGRISCTIAN 
RCHEGGQSYKIGDKWRRPHETGGYMLECLCLGNGKGEWTCKPIAEKCFDHAAGTSYVVGETWEKPYQGWM 
MVDCTCLGEGNGRITCTSRNRCNDQDTRTSYRIGDTWSKKDNRGNLLQCVCTGNGRGEWKCERHALQSAS 
AGSGSFTDVRTAIYQPQTHPQPAPYGHCVTDSGVVYSVGMQWLKSQGNKQMLCTCLGNGVSCQETAVTQT 
YGGNSNGEPCVLPFTYNGRTFYSCTTEGRQDGHLWCSTTSNYEQDQKYSFCTDHAVLVQTRGGNSNGALC 
HFPFLYNNRNYTDCTSEGRRDNMKWCGTTQNYDADQKFGFCPMAAHEEICTTNEGVMYRIGDQWDKQHDL 
GHMMRCTCVGNGRGEWACIPYSQLRDQCIVDDITYNVNDTFHKRHEEGHMLNCTCFGQGRGRWKCDPIDQ 
CQDSETRTFYQIGDSWEKFVHGVRYQCYCYGRGIGEWHCQPLQTYPGTTGPVQVIITETPSQPNSHPIQW 
NAPEPSHITKYILRWRPKTSTGRWKEATIPGHLNSYTIKGLTPGVIYEGQLISIQQYGHREVTRFDFTTS 
ASTPVTSNTVTGETAPYSPVVATSESVTEITASSFVVSWVSASDTVSGFRVEYELSEEGDEPQYLDLPST 
ATSVNIPDLLPGRKYIVNVYQISEEGKQSLILSTSQTTAPDAPPDPTVDQVDDTSIVVRWSRPQAPITGY 
RIVYSPSVEGSSTELNLPETANSVTLSDLQPGVQYNITIYAVEENQESTPVFIQQETTGTPRSDNVPPPT 
DLQFVELTDVKVTIMWTPPDSVVSGYRVEVLPVSLPGEHGQRLPVNRNTFAEITGLSPGVTYLFKVFAVH 
QGRESNPLTAQQTTKLDAPTNLQFVNETDRTVLVTWTPPRARIAGYRLTAGLTRGGQPKQYNVGPLASKY 
PLRNLQPGSEYTVTLVAVKGNQQSPKATGVFTTLQPLRSIPPYNTEVTETTIVITWTPAPRIGFKLGVRP 
SQGGEAPREVTSDSGSIVVSGLTPGVEYTYTIQVLRDGQERDAPIVNRVVTPLSPPTNLHLEANPDTGVL 
TVSWERSTTPDITGYRITTTPTNGQQGTSLEEVVHADQSSCTFENLNPGLEYNVSVYTVKDDKESAPISD 
TVVPEVPQLTDLSFVDITDSSIGLRWTPLNSSTIIGYRITVVAAGEGIPIFEDFVDSSVGYYTVTGLEPG 
IDYDISVITLINGGESAPTTLTQQTAVPPPTDLRFTNIGPDTMRVTWAPPPSIELTNLLVRYSPVKNEED 
VAELSISPSDNAVVLTNLLPGTEYLVSVSSVYEQHESIPLRGRQKTGLDSPTGFDSSDITANSFTVHWVA 
PRAPITGYIIRHHAEHSVGRPRQDRVPPSRNSITLTNLNPGTEYVVSIIAVNGREESPPLIGQQATVSDI 
PRDLEVIASTPTSLLISWEPPAVSVRYYRITYGETGGNSPVQEFTVPGSKSTATINNIKPGADYTITLYA 
VTGRGDSPASSKPVSINYKTEIDKPSQMQVTDVQDNSISVRWLPSTSPVTGYRVTTTPKNGLGPSKTKTA 
SPDQTEMTIEGLQPTVEYVVSVYAQNRNGESQPLVQTAVTNIDRPKGLAFTDVDVDSIKIAWESPQGQVS 
RYRVTYSSPEDGIRELFPAPDGEDDTAELQGLRPGSEYTVSVVALHDDMESQPLIGIQSTAIPAPTNLKF 
SQVTPTSFTAQWIAPSVQLTGYRVRVNPKEKTGPMKEINLSPDSSSVIVSGLMVATKYEVSVYALKDTLT 
SRPAQGVITTLENVSPPRRARVTDATETTITISWRTKTETITGFQVDAIPANGQTPVQRSISPDVRSYTI 
TGLQPGTDYKIHLYTLNDNARSSPVIIDASTAIDAPSNLRFLTTTPNSLLVSWQAPRARITGYIIKYEKP 
GSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALKNNQKSEPLIGRKKTDELPQLVTLPHPNLHGPEI 
LDVPSTVQKTPFITNPGYDTENGIQLPGTTHQQPSVGQQMIFEEHGFRRTTPPTAATPVRLRPRPYLPNV 
DEEVQIGHVPRGDVDYHLYPHVPGLNPNASTGQEALSQTTISWTPFQESSEYIISCQPVGTDEEPLQFQV 
PGTSTSATLTGLTRGVTYNIIVEALQNQRRHKVREEVVTVGNAVSEGLNQPTDDSCFDPYTVSHYAIGEE 
WERLSDAGFKLTCQCLGFGSGHFRCDSSKWCHDNGVNYKIGEKWDRQGENGQRMSCTCLGNGKGEFKCDP 
HEATCYDDGKTYHVGEQWQKEYLGAICSCTCFGGQRGWRCDNCRRPGAAEPSPDGTTGHTYNQYTQRYNQ 
RTNTNVNCPIECFMPLDVQADRDDSRE 
 
Figure 7.5 - Sequence of fibronectin 1 (Mus musculus, NP_034363.1). Peptide bond labelling as 
described in legend of Fig. 7.1. 
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PROTOCOL I: 
PURIFICATION OF CARDOSINS 
 
 
 
1. Cardosins Extraction from Cynara cardunculus L. Pistils 
 
- Place 2g of fresh pistils in a mortar; 
- Add 12ml of sodium citrate buffer, 100mM, pH 3.5; 
- Ground until reduction to a homogeneous emulsion; 
- Centrifuge at 14,000 rpm for 10minutes; 
- Remove gently the supernatant; 
- Filter the supernatant through a membrane with a 0.2µm pore. The 
membrane should be previously hydrated (with sodium citrate buffer, 
100mM, pH 3.5). Avoid high pressure application to prevent denaturation of 
proteins). 
 
2. Size Exclusion Chromatography - Hiload Superdex 75 Semi Prep 
 
- Equilibrate the column in Tris.HCl buffer, 25mM, pH 7.6, at a flow rate of 
4ml/min; 
- Apply 10ml of the solution obtained in the previous step of cardosins 
purification to the column; 
- Approximately 45min after sample injection collect the protein fraction from 
the column until absorbance approaches the base line; this solution 
corresponds to a mixture of cardosins A0, A and B. 
 
3. Cardosins storage 
 
- Quantify cardosins solution; 
- Prepare aliquots of 2mg, lyophilise and store at -80ºC. 
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PROTOCOL II: 
CARDOSINS ACTIVITY 
 
 
1. Hydrolysis of Lys-Pro-Ala-Glu-Phe-Phe(NO2)-Ala-Leu synthetic peptide 
 
- Add 21µl (63µg) of Lys-Pro-Ala-Glu-Phe-Phe(NO2)-Ala-Leu (stock solution – 
3mg/ml in reaction buffer) to 274µl of reaction buffer234 to a final volume of 
300µl. 
- Incubate at 25ºC; 
- Start reaction by adding 0.143µg (5µl) of cardosins; 
- After 5, 10, 20, 30 minutes remove 60µl of the reaction mixture and add it to 
540µl of 1.5% TFA. Mix vigorously (vortex) in order to end the reaction. 
 
 
2. Analysis of hydrolysis products 
 
- Apply the samples to a HPLC system equipped with a reverse phase column, 
C18 (250 x 4.6mm LiChroCART™ 100 RP-18, 5µm, Merck) equilibrated with 30% 
acetonitrile (v/v) in ultra-pure water acidified with 0.1% TFA (v/v) at a flow 
rate of 0.8ml/min. Detect continuously at 254nm. 
- Elute the digestion products by raising acetonitrile concentration [to a final 
concentration of 100% acetonitrile(v/v)]. 
                                                          
234 Reaction buffer: 50mM Sodium acetate, 200mM Sodium chloride, 4% DMSO (v/v), pH 4.7. 
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PROTOCOL III: 
IMMUNOCYTOCHEMISTRY 
 
 
1. Cell preparation 
- Remove the media and rinse twice with Krebs solution or PBS. 
 
2. Cell fixation and permeabilization  
- Remove the Krebs solution or PBS and incubate with 110µl of 4% PFA in PBS 
for 10 minutes at room temperature; 
- Rinse twice with PBS; 
- Permeabilize with  0.2% Triton X-100 in PBS for 10 minutes at room 
temperature; 
- Wash 4x with PBS. 
 
3. Gelatin-blocking  
- Block with 0.2% gelatin in 0.5% Tween 20 in PBS for 90 minutos at room 
temperature; 
- Rinse once with PBS. 
 
4. Primary antibody incubation 
- Add 80µl of primary antibody dilution and incubate for 90 minutes at room 
temperature. 
- Remove and wash 6x with 0.5% Tween 20 in PBS. 
 
 
Protect from light 
5. Secondary antibody incubation 
- Add 80µl of primary antibody dilution and incubate for 90 minutes at room 
temperature. 
- Remove and wash 6x with 0.5% Tween 20 in PBS. 
 
6. Mounting 
- Identify and clean the glass slides with ethanol.  
7. Appendix  
- Wash thoroughly the coverslips 
- Pick up the coverslips with forceps and drain away the excess of buffer  
- Put a drop of fluorescent mounting medium (DAKO) and gently lay coverslip 
on top 
- Let dry for 2-3 hours at room temperature 
- Seal the coverslip border with nail malt   
- Store in -20°C freezer 
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PROTOCOL IV:  
GELATIN ZYMOGRAPHY (adapted protocol235) 
 
 
1. Gel preparation 
Prepare gels (7.5%, 10% or 12%) according to the standard procedure. During the 
running gel preparation add gelatin stock solution (10 mg/ml in H2O) to get the 
gelatin concentration of 0.1% (1 mg/ml).  
   
2. Samples preparation 
Mix one part sample with one part sample buffer (2x)(i) and let stand 10 minutes at 
room temperature. DO NOT HEAT.  
   
3. Running conditions 
Apply samples (typically 10-25 µl) and run the gel with 1x Tris-Bicine SDS Running 
Buffer(ii) according to the standard running conditions (~125V, constant voltage). 
Run time (60-120 min) will depend on the gel percentage and running buffer 
concentration and pH.  
  
4. Gel renaturation 
After running, dilute the zymogram Renaturing Buffer (10x)(iii) 1:9 with deionized 
water and incubate the gel in the buffer (100 ml for one or two mini-gels) with 
gentle agitation for 30 minutes at room temperature.  
   
5. Zymogram developing phase 
Decant the Zymogram Renaturing Buffer and replace with 1x Zymogram 
Developing Buffer(iv) (100 ml for one or two mini-gels). Equilibrate the gel for 30 
minutes at room temperature with gentle agitation then replace with fresh 1x 
Zymogram Developing Buffer and incubate at 37°C for at least four hours. Incubate 
overnight for maximum sensitivity. Incubation time can be reduced to as little as 
one hour for concentrated samples. The optimal result can be determined 
empirically by varying the sample load or incubation time.  
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6. Zymogram revelation 
Stain with Coomassie Blue R-250 for 30 minutes. For maximum contrast, use a stain 
concentration of 0.5% (w/v) instead of the usual concentration of 0.1%. Gels should 
be destained with an appropriate Coomassie R-250 destaining solution (Methanol : 
Acetic acid : Water; 50 : 10 : 40). Areas of protease activity will appear as clear 
bands against a dark blue background where the protease has digested the 
substrate.  
 
STOCK SOLUTIONS 
 
(i) Sample Buffer  (2X) 
0.5 M Tris-HCl, pH 6.8  2.5 ml 
Glycerol    2.0 ml 
10% (w/v) SDS      4.0 ml 
0.1% Bromophenol Blue    0.5 ml 
Distilled water to 10.0 ml 
 
 
  
(ii) Running Buffer (10x)  (1X) 
Tris Base 29 g  2.9 g 
Glycine 144 g    14.4 g 
SDS 10 g  1.0 g 
0.1% Bromophenol Blue    0.5 ml 
Distilled water to 1000 ml     
 
 
 pH=8.3 
(iii) Renaturing Buffer  (10x)  
Triton X-100, 25% (v/v) in 
water  
 
 
 2.9 g 
(iv) Developing Buffer (10x)  (1X)   
Tris base, 12.1 g  
Tris-HCl, 63.0 g  
 
50mM 
NaCl, 117 g   0.2M  
CaCl2, 7.4 g  5 mM  
Distilled water to 1000 ml     
 
  
                                                                                                                                                                                  
235 Liotta, L.A. and W.G. Stetler-Stevenson. Metalloproteinases and cancer invasion. (Review -1990). Semin. Cancer 
Biol.1(2): 99-106. 
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PROTOCOL V: 
RNA ISOLATION USING TRIZOL PROCEDURE 
 
1. Homogenization 
Lyse cells grown in monolayer directly in a culture dish by adding 1 ml of TRIZOL 
Reagent to a 3.5 cm diameter dish (mix gently by passing the cell lysate several 
times through a pipette).  
 
2. Phase separation 
Incubate the homogenized samples for 5 minutes at room temperature to permit 
the complete dissociation of nucleoprotein complexes. Add 0.2 ml of chloroform 
per 1 ml of TRIZOL Reagent. Cap sample tubes securely. Shake tubes vigorously by 
hand for 15 seconds and incubate them at room temperature for 2 to 3 minutes. 
Centrifuge the samples at no more than 12,000 x g for 15 minutes at 2 to 8°C. 
Following centrifugation, the mixture separates into a lower red, phenol-chloroform 
phase, an interphase, and a colorless upper aqueous phase. RNA remains 
exclusively in the aqueous phase. The volume of the aqueous phase is about 60% of 
the volume of TRIZOL Reagent used for homogenization. 
 
3. RNA precipitation 
Transfer the aqueous phase to a fresh tube236, and precipitate the RNA from the 
aqueous phase by mixing with isopropyl alcohol. Use 0.5 ml of isopropyl alcohol per 
1 ml of TRIZOL Reagent used for the initial homogenization. Incubate samples at 
room temperature for 10 minutes and centrifuge at no more than 12,000 x g for 10 
minutes at 2 to 8°C. The RNA precipitate, often invisible before centrifugation, forms 
a gel-like pellet on the side and bottom of the tube. 
 
4. RNA wash 
Remove the supernate. Wash the RNA pellet once with 75% ethanol, adding at 
least 1 ml of 75% ethanol per 1 ml of TRIZOL Reagent used for the initial 
homogenization. 
Mix the sample by vortexing and centrifuge at no more than 7,500 x g for 5 minutes 
at 2 to 8°C. 
                                                          
236 save the organic phase if isolation of DNA or protein is desired. 
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5. Redissolving the RNA 
At the end of the procedure, briefly dry the RNA pellet (air-dry or vacuum-dry for 5-
10 minutes). Do not dry the RNA by centrifugation under vacuum. It is important not 
to let the RNA pellet dry completely as this will greatly decrease its solubility. 
Dissolve RNA in RNase-free water by passing the solution a few times through a 
pipette tip, and incubating for 10 minutes at 55 to 60°C.  
 
NOTES: 
 
Reagents required: 
- Chloroform 
- Isopropyl alcohol 
- 75% Ethanol (in DEPC-treated water) 
- RNase-free water or 0.5% SDS solution [To prepare RNase-free water, draw water into 
RNase-free glass bottles. Add diethylpyrocarbonate (DEPC) to 0.01% (v/v). Let stand 
overnight and autoclave. The SDS solution must be prepared using DEPC-treated, 
autoclaved water.]  
 
Precautions for Preventing RNase Contamination: 
- RNases can be introduced accidentally into the RNA preparation at any point in the 
isolation procedure through improper technique. Because RNase activity is difficult to 
inhibit, it is essential to prevent its introduction. The following guidelines should be observed 
when working with RNA. 
- Always wear disposable gloves. Skin often contains bacteria and molds that can 
contaminate an RNA preparation and be a source of RNases. Practice good 
microbiological technique to prevent microbial contamination. 
- Use sterile, disposable plasticware and automatic pipettes reserved for RNA work to. 
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PROTOCOL VI: 
ELECTROPHORETIC SEPARATION OF PROTEINS IN DENATURING CONDITIONS 
(SDS-PAGE) 
 
1. Sample preparation 
- Place the multiwell plate on ice to proceed with cell lysis (for protein 
extraction). 
-  Remove the media and rinse twice with Krebs solution or PBS. 
- Thoroughly, scraping the cells off the plates and resuspending them in lysis 
buffer237.  
- Dilute samples with 35-40µg of total protein in denaturing solution238 (1:1; v:v), 
heat them at 100ºC for 3-5min and apply to the polymerised gel. Use an 
appropriate molecular weight pre-stained marker.  
 
2. Running gel – 7.5% 
Add the following chemicals sequentially: 
- 4.765ml mili-Q water; 
- 3.36ml Tris 1.5M pH 8.8; 
- 1.875ml acrylamide:bisacrylamide (40%, w/v); 
- 200µl SDS (10%, w/v); 
- 100µl ammonium persulphate (10%, w/v); 
- gently homogenise; 
- 5µl TEMED. 
 
Apply the homogenised solution, immediately, to the assembled system, place the 
combs on the top of the gel and allow it to polymerise. 
 
3. Running buffer 
Apply samples (35-40 µg) and run the gel with 1x Tris-Bicine SDS Running Buffer239 
according to the standard running conditions (~125V, constant voltage). Run time 
(60-120 min) will depend on the molecular weight of the protein under study.  
 
                                                          
237
 Lysis buffer: 25mM Tris, 2.5 mM EDTA, 2.5 EGTA, 1% Triton X-100, supplied with 1mM DTT, 1mM PMSF 
and 52.57µM leupeptin. 
238 Denaturing solution: 2% β-mercaptoethanol (v/v); 2% SDS (w/v); 8M Urea; 100mM Tris:Bicine 
239 SDS-Runing buffer: 100mM Tris:Bicine; 0.1% SDS (w/v). 
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PROTOCOL VII: 
WESTERN BLOT- IMMUNOBLOTTING PROPOSES 
(Wear gloves to avoid contamination) 
 
1. Assembling Western blotting apparatus 
- Cut a piece of nitrocellulose membrane and two pieces of filter paper 
(3MM) to the dimensions of the gel; 
- Equilibrate the gel and soak the membrane, filter paper (3MM) and fiber 
pads in transfer buffer240 (15min); 
- Prepare the gel sandwich as follows (Figure 7.1): 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.6 - Schematic representation of how to assemble a blot sandwich (Bio-Rad, instructions 
manual): a) Place one pre-wetted fibber pad on the black plate of the cassette; b) Place a sheet of 
3MM paper on the fibber pad; c) Place the equilibrated gel on the filter paper; d) Place the pre-
wetted membrane on the gel (remove any air bubbles which may have formed; use a glass tube to 
gently roll air bubbles out); e) Complete the sandwich by placing a piece of filter paper on the 
membrane and the last fibber pad. 
 
 
- Close the cassette firmly, being careful not to move the gel and filter paper 
sandwich. 
- Place in tank and completely fill the tank with buffer (attention: black plate 
of the cassette must be placed next to negative pole). 
- Add a stir bar (to help maintain even buffer temperature and ion distribution 
in the tank) and run the blot. 
 
                                                          
240 Transfer buffer: 25mM Tris, 192mM Glicine, pH 8.2; 10% (v/v) methanol. 
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2. Transfer conditions 
- 40mA (constant); 
- ∼17 hours; 
The transfer tank was coupled to a refrigerated unit to improve heat dissipation. 
These conditions are suitable for high molecular mass proteins. 
 
3. Disassemble transfer apparatus 
- Carefully disassemble the transfer apparatus. Using tweezers or forceps, 
place the nitrocellulose membrane in container and wash for 10 min in 0.1% 
TBS-T241. 
 
4. Blocking membrane  
- Block the membrane with 5% skim milk in 0.1% TBS-T for 1-2 hours. 
 
5. Primary antibody incubation 
- Prepare the primary antibody using the recommended dilution in 0.1% TBS-T, 
1.5% skim milk; 
- Incubate overnight with gentle rocking in cold room. 
 
6. Secondary antibody incubation 
- Wash three times for 5 minutes with 0.1% TBS-T; 
- Dilute the secondary antibody to the desired concentration in 0.1% TBS-T and 
incubate for 1-2 hours with gentle rocking at room temperature; 
- Wash the membrane three times in 0.1% TBS-T. 
 
Protect from light 
 
7. Visualise with ECL 
- Prepare ECL solution for detection: mix equal volume of ECL reagent 1 and 
2, (1:1) with final volume regarding of 0.125 ml/cm2; 
- Remove excess buffer from the membrane by draining the membrane over 
a piece of filter paper and briefly touching the edge of the membrane to 
                                                          
241
 Tris-buffered saline with 0.1% Tween 20 
7. Appendix  
the paper. Add the mixed ECL reagent to the surface of the membrane for 1 
minute; 
- Drain off the ECL reagent and wrap the blot in a plastic (transparent) wrap; 
- Tape membrane to the inside film cassette; 
- Add 1 sheet of x-ray film (Kodak) to the cassette. Expose membrane to film. 
It will probably be necessary to do several different exposures to find out the 
best exposure. 
- Develop the film. 
 
 
